<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency","wgTitle":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","wgCurRevisionId":668293620,"wgRevisionId":668293620,"wgArticleId":802065,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles with contributors link","Articles needing additional references from September 2012","All articles needing additional references","NPOV disputes from September 2012","All NPOV disputes","Articles that use a Medicine navs subtemplate","Adrenal gland disorders","Autosomal recessive disorders","Cholesterol and steroid metabolism disorders"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency","wgRelevantArticleId":802065,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/f/fc/17-Hydroxyprogesterone.svg/100px-17-Hydroxyprogesterone.svg.png","wgULSAcceptLanguageList":["en-us","en"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q4127185"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Congenital adrenal hyperplasia due to 21-hydroxylase deficiency</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Congenital adrenal hyperplasia due to 21-hydroxylase deficiency</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:17-Hydroxyprogesterone.svg" class="image"><img alt="17-Hydroxyprogesterone.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fc/17-Hydroxyprogesterone.svg/230px-17-Hydroxyprogesterone.svg.png" width="230" height="148" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fc/17-Hydroxyprogesterone.svg/345px-17-Hydroxyprogesterone.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fc/17-Hydroxyprogesterone.svg/460px-17-Hydroxyprogesterone.svg.png 2x" data-file-width="512" data-file-height="330" /></a>
<div>Deficient <a href="/wiki/21-Hydroxylase" title="21-Hydroxylase">21-Hydroxylase</a> can lead to accumulation of <a href="/wiki/17-Hydroxyprogesterone" title="17-Hydroxyprogesterone">17-Hydroxyprogesterone</a></div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/E25.0">E25.0</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=255.2">255.2</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/201910">201910</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb1854.htm">1854</a></td>
</tr>
</table>
<p><b>Congenital adrenal hyperplasia due to 21-hydroxylase deficiency</b> (<b>21-OH CAH</b>), in all its forms, accounts for over 95% of diagnosed cases of <a href="/wiki/Congenital_adrenal_hyperplasia" title="Congenital adrenal hyperplasia">congenital adrenal hyperplasia</a>,<sup id="cite_ref-pmid10857554_1-0" class="reference"><a href="#cite_note-pmid10857554-1"><span>[</span>1<span>]</span></a></sup> and "CAH" in most contexts refers to <a href="/wiki/21-hydroxylase" title="21-hydroxylase" class="mw-redirect">21-hydroxylase</a> deficiency. An overview of the other types of CAH is presented in the main <a href="/wiki/Congenital_adrenal_hyperplasia" title="Congenital adrenal hyperplasia">article</a>.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Degree_of_severity"><span class="tocnumber">1</span> <span class="toctext">Degree of severity</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Genetic_prevalence"><span class="tocnumber">2</span> <span class="toctext">Genetic prevalence</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Severe.2C_early_onset_21-hydroxylase_deficient_CAH"><span class="tocnumber">4</span> <span class="toctext">Severe, early onset 21-hydroxylase deficient CAH</span></a>
<ul>
<li class="toclevel-2 tocsection-5"><a href="#Salt-wasting_crises_in_infancy"><span class="tocnumber">4.1</span> <span class="toctext">Salt-wasting crises in infancy</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Virilization_of_female_infants"><span class="tocnumber">4.2</span> <span class="toctext">Virilization of female infants</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Sex_assignment_issues_and_controversies"><span class="tocnumber">4.3</span> <span class="toctext">Sex assignment issues and controversies</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-8"><a href="#Long-term_management_of_CAH"><span class="tocnumber">5</span> <span class="toctext">Long-term management of CAH</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#Testicular_Adrenal_Rest_Tumors"><span class="tocnumber">6</span> <span class="toctext">Testicular Adrenal Rest Tumors</span></a>
<ul>
<li class="toclevel-2 tocsection-10"><a href="#Hormone_replacement"><span class="tocnumber">6.1</span> <span class="toctext">Hormone replacement</span></a>
<ul>
<li class="toclevel-3 tocsection-11"><a href="#Stress_coverage.2C_crisis_prevention.2C_parental_education"><span class="tocnumber">6.1.1</span> <span class="toctext">Stress coverage, crisis prevention, parental education</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-12"><a href="#Reconstructive_surgery"><span class="tocnumber">6.2</span> <span class="toctext">Reconstructive surgery</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#Optimizing_growth_in_CAH"><span class="tocnumber">6.3</span> <span class="toctext">Optimizing growth in CAH</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#Preventing_hyperandrogenism_and_optimizing_fertility"><span class="tocnumber">6.4</span> <span class="toctext">Preventing hyperandrogenism and optimizing fertility</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#Psychosexual_development_and_issues"><span class="tocnumber">6.5</span> <span class="toctext">Psychosexual development and issues</span></a></li>
<li class="toclevel-2 tocsection-16"><a href="#Newborn_screening"><span class="tocnumber">6.6</span> <span class="toctext">Newborn screening</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-17"><a href="#Prenatal_diagnosis_and_treatment"><span class="tocnumber">7</span> <span class="toctext">Prenatal diagnosis and treatment</span></a></li>
<li class="toclevel-1 tocsection-18"><a href="#Childhood-onset_.28simple_virilizing.29_CAH"><span class="tocnumber">8</span> <span class="toctext">Childhood-onset (simple virilizing) CAH</span></a></li>
<li class="toclevel-1 tocsection-19"><a href="#Late_onset_.28nonclassical.29_CAH"><span class="tocnumber">9</span> <span class="toctext">Late onset (nonclassical) CAH</span></a></li>
<li class="toclevel-1 tocsection-20"><a href="#See_also"><span class="tocnumber">10</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-21"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-22"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Degree_of_severity">Degree of severity</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=1" title="Edit section: Degree of severity">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The condition can be classified into "salt-wasting", "simple virilizing", and "non-classical" forms.</p>
<table class="wikitable">
<tr>
<th>Type</th>
<th><a href="/wiki/Sex_steroid" title="Sex steroid">Sex steroid</a> effects</th>
<th>Other effects</th>
</tr>
<tr>
<td>Severe 21-hydroxylase deficiency causes <i><b>salt-wasting CAH</b></i></td>
<td>The most common cause of <a href="/wiki/Ambiguous_genitalia" title="Ambiguous genitalia" class="mw-redirect">ambiguous genitalia</a> due to prenatal <a href="/wiki/Virilization" title="Virilization">virilization</a> of genetically female (XX) infants.</td>
<td>Life-threatening vomiting and <a href="/wiki/Dehydration" title="Dehydration">dehydration</a> occurring within the first few weeks of life. Aldosterone and cortisol levels are both reduced.</td>
</tr>
<tr>
<td>Moderate 21-hydroxylase deficiency is referred to as <i><b>simple virilizing CAH</b></i></td>
<td>Typically is recognized as causing virilization of prepubertal children.</td>
<td>Cortisol is reduced, but aldosterone is not.</td>
</tr>
<tr>
<td>Still milder forms of 21-hydroxylase deficiency are referred to as <i><b>non-classical CAH</b></i></td>
<td>Can cause <a href="/wiki/Androgen" title="Androgen">androgen</a> effects and <a href="/wiki/Infertility" title="Infertility">infertility</a> in adolescent and adult women.</td>
<td>Neither aldosterone nor cortisol are reduced.</td>
</tr>
</table>
<p>The salt-wasting and simple virilizing types are sometimes grouped together as "classical".<sup id="cite_ref-pmid15988383_2-0" class="reference"><a href="#cite_note-pmid15988383-2"><span>[</span>2<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Genetic_prevalence">Genetic prevalence</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=2" title="Edit section: Genetic prevalence">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Autorecessive.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Autorecessive.svg/220px-Autorecessive.svg.png" width="220" height="257" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Autorecessive.svg/330px-Autorecessive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Autorecessive.svg/440px-Autorecessive.svg.png 2x" data-file-width="1350" data-file-height="1580" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Autorecessive.svg" class="internal" title="Enlarge"></a></div>
21-hydroxylase CAH is inherited in an <a href="/wiki/Autosomal_recessive" title="Autosomal recessive" class="mw-redirect">autosomal recessive</a> fashion</div>
</div>
</div>
<p>The <i><a href="/wiki/Cytochrome_P450" title="Cytochrome P450">CYP</a><a href="/wiki/21-Hydroxylase" title="21-Hydroxylase">21A2</a></i> gene for the P450c21 enzyme (also known as <a href="/wiki/21-hydroxylase" title="21-hydroxylase" class="mw-redirect">21-hydroxylase</a>) is at 6p21.3,<sup id="cite_ref-pmid19228439_3-0" class="reference"><a href="#cite_note-pmid19228439-3"><span>[</span>3<span>]</span></a></sup> amid genes <i>HLA B</i> and <i>HLA DR</i> coding for the major human histocompatibility loci (<a href="/wiki/Human_leukocyte_antigen" title="Human leukocyte antigen">HLA</a>). <i>CYP21A2</i> is paired with a nonfunctional <a href="/wiki/Pseudogene" title="Pseudogene">pseudogene</a> <i>CYP21A1P</i>. Scores of abnormal <a href="/wiki/Allele" title="Allele">alleles</a> of CYP21A2 have been documented, most arising from <a href="/wiki/Genetic_recombination" title="Genetic recombination">recombinations</a> of homologous regions of <i>CYP21A2</i> and <i>CYP21A1P</i>. Differences in residual enzyme activity of the various alleles account for the various degrees of severity of the disease. Inheritance of all forms of 21-hydroxylase CAH is <a href="/wiki/Autosomal_recessive" title="Autosomal recessive" class="mw-redirect">autosomal recessive</a>.</p>
<p>Persons affected by any forms of the disease have two abnormal alleles, and both parents are usually <a href="/wiki/Heterozygote" title="Heterozygote" class="mw-redirect">heterozygotes</a> (or <a href="/wiki/Genetic_carrier" title="Genetic carrier">carriers</a>). When both parents carry an abnormal allele, each child has a 25% chance of having the disease, a 50% chance of being a carrier like the parents, and a 25% chance of having two normal genes.</p>
<p>It is now possible to test for <a href="/wiki/Heterozygote" title="Heterozygote" class="mw-redirect">heterozygosity</a> by measuring 17-hydroxyprogesterone elevation after <a href="/wiki/ACTH" title="ACTH" class="mw-redirect">ACTH</a> stimulation, or more recently by direct gene sequencing.</p>
<p>The incidence of 21-hydroxylase deficient CAH detectable in childhood is about 1 in 15,000 births. The severe salt-wasting form accounts for the majority of these cases, which is high enough that many states and countries routinely include it in mandated <a href="/wiki/Newborn_screening" title="Newborn screening">newborn screening</a> tests. The incidence of simple virilizing CAH is about 1 in 60,000 children.</p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=3" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:452px;"><a href="/wiki/File:Steroidogenesis.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/13/Steroidogenesis.svg/450px-Steroidogenesis.svg.png" width="450" height="399" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/13/Steroidogenesis.svg/675px-Steroidogenesis.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/13/Steroidogenesis.svg/900px-Steroidogenesis.svg.png 2x" data-file-width="1245" data-file-height="1105" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Steroidogenesis.svg" class="internal" title="Enlarge"></a></div>
Human <a href="/wiki/Steroidogenesis" title="Steroidogenesis" class="mw-redirect">steroidogenesis</a>, showing <i>21-α hydroxylase</i> at upper center, with pathways to aldosterone and cortisol at right, and pathways to androgens at left.</div>
</div>
</div>
<p>The enzyme P450c21, commonly referred to as 21-hydroxylase (21-OH), is embedded in the smooth <a href="/wiki/Endoplasmic_reticulum" title="Endoplasmic reticulum">endoplasmic reticulum</a> of the cells of the <a href="/wiki/Adrenal_gland" title="Adrenal gland">adrenal cortex</a>. It catalyzes <a href="/wiki/Hydroxylation" title="Hydroxylation">hydroxylation</a> of <a href="/wiki/17-hydroxyprogesterone" title="17-hydroxyprogesterone" class="mw-redirect">17-hydroxyprogesterone</a> to 11-deoxycortisol in the <a href="/wiki/Glucocorticoid" title="Glucocorticoid">glucocorticoid</a> pathway, which starts from <a href="/wiki/Pregnenolone" title="Pregnenolone">pregnenolone</a> and finishes with <a href="/wiki/Cortisol" title="Cortisol">cortisol</a>. It also catalyzes hydroxylation of <a href="/wiki/Progesterone" title="Progesterone">progesterone</a> to 11-deoxycorticosterone (DOC) in the <a href="/wiki/Mineralocorticoid" title="Mineralocorticoid">mineralocorticoid</a> pathway on its way from pregnenolone to <a href="/wiki/Aldosterone" title="Aldosterone">aldosterone</a>.</p>
<p>Deficient activity of this enzyme reduces the efficiency of cortisol synthesis, with consequent hyperplasia of the adrenal cortex and elevation of <a href="/wiki/ACTH" title="ACTH" class="mw-redirect">ACTH</a> levels. ACTH stimulates uptake of <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a> and synthesis of pregnenolone. Steroid precursors up to and including progesterone, 17-hydroxypregnenolone, and especially 17-hydroxyprogesterone (17OHP) accumulate in the adrenal cortex and in circulating blood. Blood levels of 17OHP can reach 10-1000 times the normal concentration.</p>
<p>Since 21-hydroxylase activity is not involved in synthesis of <a href="/wiki/Androgen" title="Androgen">androgens</a>, a substantial fraction of the large amounts of 17-hydroxypregnenolone is diverted to synthesis of <a href="/wiki/DHEA" title="DHEA" class="mw-redirect">DHEA</a>, <a href="/wiki/Androstenedione" title="Androstenedione">androstenedione</a>, and <a href="/wiki/Testosterone" title="Testosterone">testosterone</a> beginning in the third month of fetal life in both sexes.</p>
<p>Synthesis of <a href="/wiki/Aldosterone" title="Aldosterone">aldosterone</a> is also dependent on 21-hydroxylase activity. Although fetal production is impaired, it causes no prenatal effects, as the <a href="/wiki/Placenta" title="Placenta">placental</a> connection allows maternal blood to "<a href="/wiki/Dialysis" title="Dialysis">dialyze</a>" the fetus and maintain both <a href="/wiki/Electrolyte" title="Electrolyte">electrolyte</a> balance and blood volume.</p>
<h2><span class="mw-headline" id="Severe.2C_early_onset_21-hydroxylase_deficient_CAH">Severe, early onset 21-hydroxylase deficient CAH</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=4" title="Edit section: Severe, early onset 21-hydroxylase deficient CAH">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The two most serious neonatal consequences of 21-hydroxylase deficiency occur when there is minimal measurable hydroxylase activity from prenatal life: life-threatening salt-wasting crises in the first month of life for XX and XY infants alike and severe virilization of female infants.</p>
<h3><span class="mw-headline" id="Salt-wasting_crises_in_infancy">Salt-wasting crises in infancy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=5" title="Edit section: Salt-wasting crises in infancy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The excessive amounts of adrenal testosterone produce little effect on the genitalia of male infants with severe CAH. If a male infant with CAH is not detected by <a href="/wiki/Newborn_screening" title="Newborn screening">newborn screening</a>, he will appear healthy and normal and be quickly discharged home to his family.</p>
<p>However, the lack of aldosterone results in a high rate of <a href="/wiki/Sodium" title="Sodium">sodium</a> loss in the urine. Urinary sodium concentrations may exceed 50 mEq/L. With this rate of salt loss, the infant cannot maintain blood volume, and <a href="/wiki/Hyponatremia" title="Hyponatremia">hyponatremic</a> <a href="/wiki/Dehydration" title="Dehydration">dehydration</a> begins to develop by the end of the first week of life. <a href="/wiki/Potassium" title="Potassium">Potassium</a> and <a href="/wiki/Acid" title="Acid">acid</a> excretion are also impaired when <a href="/wiki/Mineralocorticoid" title="Mineralocorticoid">mineralocorticoid</a> activity is deficient, and <a href="/wiki/Hyperkalemia" title="Hyperkalemia">hyperkalemia</a> and <a href="/wiki/Metabolic_acidosis" title="Metabolic acidosis">metabolic acidosis</a> gradually develop. Ability to maintain circulation is further limited by the effect of cortisol deficiency. The early symptoms are spitting and poor weight gain, but most infants with severe CAH develop vomiting, severe dehydration, and circulatory collapse (<a href="/wiki/Shock_(circulatory)" title="Shock (circulatory)">shock</a>) by the second or third week of life.</p>
<p>When brought to a hospital, the 1-3 week old infant will be both underweight and dehydrated by appearance. Blood pressure may be low. Basic chemistries will reveal <a href="/wiki/Hyponatremia" title="Hyponatremia">hyponatremia</a>, with a serum Na<sup>+</sup> typically between 105 and 125 mEq/L. <a href="/wiki/Hyperkalemia" title="Hyperkalemia">Hyperkalemia</a> in these infants can be extreme—levels of K<sup>+</sup> above 10 mEq/L are not unusual—as can the degree of <a href="/wiki/Metabolic_acidosis" title="Metabolic acidosis">metabolic acidosis</a>. <a href="/wiki/Hypoglycemia" title="Hypoglycemia">Hypoglycemia</a> may be present. This is termed a salt-wasting crisis and rapidly causes death if not treated.</p>
<p>As ill as these infants can be, they respond rapidly to treatment with hydrocortisone and intravenous saline and dextrose quickly restores blood volume, blood pressure, and body sodium content, and reverses the hyperkalemia. With appropriate treatment, most infants are out of danger within 24 hours.</p>
<h3><span class="mw-headline" id="Virilization_of_female_infants">Virilization of female infants</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=6" title="Edit section: Virilization of female infants">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Virilization of genetically female (XX) infants usually produces obvious <a href="/wiki/Ambiguous_genitalia" title="Ambiguous genitalia" class="mw-redirect">genital ambiguity</a>. Inside the pelvis, the <a href="/wiki/Ovary" title="Ovary">ovaries</a> are normal and since they have not been exposed to testicular <a href="/wiki/Antimullerian_hormone" title="Antimullerian hormone" class="mw-redirect">antimullerian hormone</a> (MIF), the <a href="/wiki/Uterus" title="Uterus">uterus</a>, <a href="/wiki/Fallopian_tube" title="Fallopian tube">fallopian tubes</a>, upper <a href="/wiki/Vagina" title="Vagina">vagina</a>, and other mullerian structures are normally formed as well. However, the high levels of testosterone in the blood can enlarge the <a href="/wiki/Phallus" title="Phallus">phallus</a>, partially or completely close the vaginal opening, enclose the <a href="/wiki/Urethra" title="Urethra">urethral</a> groove so that it opens at the base of the phallus, on the shaft or even at the tip like a boy. Testosterone can cause the <a href="/wiki/Labia_(genitalia)" title="Labia (genitalia)" class="mw-redirect">labial</a> skin to become as thin and rugated as a <a href="/wiki/Scrotum" title="Scrotum">scrotum</a>, but cannot produce palpable gonads (i.e., testes) in the folds.</p>
<p>Thus, depending on the severity of hyperandrogenism, a female infant can be mildly affected, obviously ambiguous, or so severely virilized as to appear to be a male. <a href="/wiki/Andrea_Prader" title="Andrea Prader">Andrea Prader</a> devised the following <a href="/wiki/Prader_scale" title="Prader scale">Prader scale</a> as a way of describing the degree of virilization.</p>
<ul>
<li>An infant at stage 1 has a mildly large <a href="/wiki/Clitoris" title="Clitoris">clitoris</a> and slightly reduced vaginal opening size. This degree may go unnoticed or may be simply assumed to be within normal variation.</li>
<li>Stages 2 and 3 represent progressively more severe degrees of virilization. The genitalia are obviously abnormal to the eye, with a phallus intermediate in size and a small vaginal opening.</li>
<li>Stage 4 looks more male than female, with an empty scrotum and a phallus the size of a normal penis, but not quite free enough of the perineum to be pulled onto the abdomen toward the umbilicus (i.e., what is termed a <a href="/wiki/Chordee" title="Chordee">chordee</a> in a male). The single small urethral/vaginal opening at the base or on the shaft of the phallus would be considered a <a href="/wiki/Hypospadias" title="Hypospadias">hypospadias</a> in a male. X-rays taken after dye injection into this opening reveal the internal connection with the upper vagina and uterus. This common opening can predispose to <a href="/wiki/Urinary_obstruction" title="Urinary obstruction" class="mw-redirect">urinary obstruction</a> and <a href="/wiki/Urinary_tract_infection" title="Urinary tract infection">infection</a>.</li>
<li>Stage 5 denotes complete male virilization, with a normally formed penis with the urethral opening at or near the tip. The scrotum is normally formed but empty. The internal pelvic organs include normal ovaries and uterus, and the vagina connects internally with the urethra as in Stage 4. These infants are not visibly ambiguous, and are usually assumed to be ordinary boys with <a href="/wiki/Cryptorchidism" title="Cryptorchidism">undescended testes</a>. In most cases, the diagnosis of CAH is not suspected until signs of salt-wasting develop a week later.</li>
</ul>
<p>When the genitalia are determined to be ambiguous at birth, CAH is one of the leading diagnostic possibilities. Evaluation reveals the presence of a uterus, extreme elevation of 17OHP, levels of testosterone approaching or exceeding the male range but low <a href="/wiki/Antimullerian_hormone" title="Antimullerian hormone" class="mw-redirect">AMH</a> levels. The karyotype is that of an ordinary female: 46,XX. With this information, the diagnosis of CAH is readily made and female sex confirmed.</p>
<p>Evaluation of ambiguous genitalia is described in detail <a href="/wiki/Ambiguous_genitalia" title="Ambiguous genitalia" class="mw-redirect">elsewhere</a>. In most cases it is possible to confirm and <a href="/wiki/Sex_assignment" title="Sex assignment">assign</a> female sex within 12–36 hours of birth. The exception are the rare, completely virilized genetic females (Prader stage 5), who present the most challenging assignment and surgery dilemmas, discussed below.</p>
<p>When the degree of ambiguity is obvious, corrective surgery is usually offered and performed. As reconstructive surgery on infant genitalia has become a focus of controversy, the issues are described in more detail below.</p>
<h3><span class="mw-headline" id="Sex_assignment_issues_and_controversies">Sex assignment issues and controversies</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=7" title="Edit section: Sex assignment issues and controversies">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>There are no difficulties <a href="/wiki/Sex_assignment" title="Sex assignment">assigning</a> appropriate sex for most infants with CAH. Genetic males have normal male genitalia and gonads and simply need hormone replacement. Most virilized females are assigned and raised as girls even if their genitalia are ambiguous or look more male than female. They have normal ovaries and uterus and potential fertility with hormone replacement and <a href="/wiki/Intersex_surgery" title="Intersex surgery">surgery</a>. However, the dilemmas surrounding <a href="/wiki/Sex_assignment" title="Sex assignment">sex assignment</a> of the most severely virilized XX infants have helped shape our understanding of <a href="/wiki/Gender_identity" title="Gender identity">gender identity</a> and <a href="/wiki/Sexual_orientation" title="Sexual orientation">sexual orientation</a>, and continue to be a subject of debate.</p>
<p>Until the 1950s, some virilized XX infants were assigned and raised as girls, and some as boys. Most developed gender identities congruent with their sex of rearing. In a few cases of male rearing, a <a href="/wiki/Sex_assignment#Reassignment_of_sex_or_gender" title="Sex assignment">sex reassignment</a> was attempted in mid-childhood when newly discovered karyotyping revealed "female" chromosomes. These reassignments were rarely successful, leading <a href="/wiki/John_Money" title="John Money">John Money</a> and other influential psychologists and physicians to conclude that gender identity was (1) unrelated to chromosomes, (2) primarily a result of social learning, and (3) could not be easily changed after infancy.</p>
<p>By the 1960s, CAH was well understood, <a href="/wiki/Karyotype" title="Karyotype">karyotyping</a> was routine, and standard management was to assign and raise all children with CAH according to their <a href="/wiki/Gonad" title="Gonad">gonads</a> and karyotypes, no matter how virilized. Markedly virilized girls were usually referred to a <a href="/wiki/Pediatric_surgery" title="Pediatric surgery">pediatric surgeon</a>, often a <a href="/wiki/Pediatric_urology" title="Pediatric urology">pediatric urologist</a> for a <a href="/wiki/Intersex_surgery" title="Intersex surgery">reconstructive vaginoplasty and clitoral reduction</a> or recession—surgery to create or enlarge a vaginal opening and reduce the size or protrusion of the clitoris. This approach was designed to preserve fertility for both sexes and remains the standard management, but two aspects of this management have been challenged: assignment of completely virilized genetic females and the value and age of corrective surgery.</p>
<p>The first questions about assignment were raised in the early 1980s when Money and others reported an unexpectedly high rate of failure to achieve normal adult sexual relationships (i.e., heterosexual orientation, marriage, and children) in grown women with CAH (though all had female gender identities). However, the sample was small, and results seemed interpretable in many ways: selection bias, early hormone effects on orientation, or sexual dysfunction created by residual body abnormalities or by the genital surgery itself. From a perspective two decades later, the report was one of the first pieces of evidence that the standard management paradigm was not always producing hoped-for outcomes.</p>
<p>Despite these concerns, no significant opposition to standard management arose until the mid-1990s, when a confluence of evidence and opinion from several sources led to a re-examination of outcomes. Several intersex support and advocacy groups (e.g., the <a href="/wiki/Intersex_Society_of_North_America" title="Intersex Society of North America">Intersex Society of North America</a>) began to publicly criticize infant genital surgery based on unsatisfactory outcomes of some adults who had been operated on as infants. Their complaints were that they had reduced ability to enjoy sexual relations or that they resented not having had the choice of gender assignment or surgical reconstruction left until they were old enough to participate. (<i>See <a href="/wiki/History_of_intersex_surgery" title="History of intersex surgery">History of intersex surgery</a>.</i>)</p>
<p>In 1997, influential articles by Reiner, <a href="/wiki/Milton_Diamond" title="Milton Diamond">Diamond</a>, and Sigmundson advocated <i>consideration</i> of (1) male sex assignment in the unambiguously male XX infants (most of whom are considered male until the CAH is recognized at 1–2 weeks of age), and (2) delaying reconstructive surgery until the patient is old enough to participate in the decision. (<i>See <a href="/wiki/Ambiguous_genitalia" title="Ambiguous genitalia" class="mw-redirect">Ambiguous genitalia</a> and <a href="/wiki/Intersex" title="Intersex">Intersex</a> for more on this debate, as well as complete citations.)</i></p>
<p>Although the standard management approach remains "standard", more time and consideration are being given in many cases to explaining alternatives to parents and a small number of XX children with unambiguously male external genitalia are again being raised as boys.</p>
<h2><span class="mw-headline" id="Long-term_management_of_CAH">Long-term management of CAH</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=8" title="Edit section: Long-term management of CAH">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Management of infants and children with CAH is complex and warrants long term care in a <a href="/wiki/Pediatric_endocrinology" title="Pediatric endocrinology">pediatric endocrine clinic</a>. After the diagnosis is confirmed, and any salt-wasting crisis averted or reversed, major management issues include:</p>
<ol>
<li>Initiating and monitoring hormone replacement</li>
<li>Stress coverage, crisis prevention, parental education</li>
<li>Reconstructive surgery</li>
<li>Optimizing growth</li>
<li>Optimizing androgen suppression and fertility in women with CAH</li>
</ol>
<h2><span class="mw-headline" id="Testicular_Adrenal_Rest_Tumors">Testicular Adrenal Rest Tumors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=9" title="Edit section: Testicular Adrenal Rest Tumors">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Infertility observed in adult males with congenital adrenal hyperplasia (CAH) has been associated with testicular adrenal rest tumors (TART) that may originate during childhood. TART in prepubertal males with classic CAH could be found during childhood (20%). Martinez-Aguayo et al. reported differences in markers of gonadal function in a subgroup of patients, especially in those with inadequate control.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Hormone_replacement">Hormone replacement</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=10" title="Edit section: Hormone replacement">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The primary goals of hormone replacement are to protect from <a href="/wiki/Adrenal_insufficiency" title="Adrenal insufficiency">adrenal insufficiency</a> and to suppress the excessive adrenal <a href="/wiki/Androgen" title="Androgen">androgen</a> production.</p>
<p><a href="/wiki/Glucocorticoid" title="Glucocorticoid">Glucocorticoids</a> are provided to all children and adults with all but the mildest and latest-onset forms of CAH. The glucocorticoids provide a reliable substitute for <a href="/wiki/Cortisol" title="Cortisol">cortisol</a>, thereby reducing <a href="/wiki/ACTH" title="ACTH" class="mw-redirect">ACTH</a> levels. Reducing ACTH also reduces the stimulus for continued hyperplasia and overproduction of androgens. In other words, glucocorticoid replacement is the primary method of reducing the excessive adrenal androgen production in both sexes. A number of glucocorticoids are available for therapeutic use. <a href="/wiki/Hydrocortisone" title="Hydrocortisone" class="mw-redirect">Hydrocortisone</a> or liquid <a href="/wiki/Prednisolone" title="Prednisolone">prednisolone</a> is preferred in infancy and childhood, and <a href="/wiki/Prednisone" title="Prednisone">prednisone</a> or <a href="/wiki/Dexamethasone" title="Dexamethasone">dexamethasone</a> are often more convenient for adults.</p>
<p>The glucocorticoid dose is typically started at the low end of physiologic replacement (6–12&#160;mg/m² but is adjusted throughout childhood to prevent both growth suppression from too much glucocorticoid and androgen escape from too little. Serum levels of <a href="/wiki/17-hydroxyprogesterone" title="17-hydroxyprogesterone" class="mw-redirect">17OHP</a>, <a href="/wiki/Testosterone" title="Testosterone">testosterone</a>, <a href="/wiki/Androstenedione" title="Androstenedione">androstenedione</a>, and other adrenal steroids are followed for additional information, but may not be entirely normalized even with optimal treatment. (<i>See <a href="/wiki/Glucocorticoid" title="Glucocorticoid">Glucocorticoid</a> for more on this topic.</i>)</p>
<p><a href="/wiki/Mineralocorticoid" title="Mineralocorticoid">Mineralocorticoids</a> are replaced in all infants with salt-wasting and in most patients with elevated <a href="/wiki/Renin" title="Renin">renin</a> levels. <a href="/wiki/Fludrocortisone" title="Fludrocortisone">Fludrocortisone</a> is the only pharmaceutically available mineralocorticoid and is usually used in doses of 0.05 to 2&#160;mg daily. <a href="/wiki/Electrolyte" title="Electrolyte">Electrolytes</a>, renin, and <a href="/wiki/Blood_pressure" title="Blood pressure">blood pressure</a> levels are followed to optimize the dose.</p>
<h4><span class="mw-headline" id="Stress_coverage.2C_crisis_prevention.2C_parental_education">Stress coverage, crisis prevention, parental education</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=11" title="Edit section: Stress coverage, crisis prevention, parental education">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Even after diagnosis and initiation of treatment, a small percentage of children and adults with infancy or childhood onset CAH die of adrenal crisis. Deaths from this are entirely avoidable if the child and family understand that the daily glucocorticoids cannot be allowed to be interrupted by an illness. When a person is well, missing a dose, or even several doses, may produce little in the way of immediate symptoms. However, glucocorticoid needs are increased during illness and stress, and <a href="/wiki/Missed_dose" title="Missed dose" class="mw-redirect">missed doses</a> during an illness such as the "flu" (or viral gastroenteritis) can lead within hours to reduced blood pressure, <a href="/wiki/Shock_(circulatory)" title="Shock (circulatory)">shock</a>, and death.</p>
<p>To prevent this, all persons taking replacement glucocorticoids are taught to increase their doses in the event of illness, surgery, severe injury, or severe exhaustion. More importantly, they are taught that vomiting warrants an injection within hours of hydrocortisone (e.g., SoluCortef) or other glucocorticoid. This recommendation applies to both children and adults. Because young children are more susceptible to vomiting illnesses than adults, pediatric endocrinologists usually teach parents how to give hydrocortisone injections.</p>
<p>As an additional precaution, persons with <a href="/wiki/Adrenal_insufficiency" title="Adrenal insufficiency">adrenal insufficiency</a> are advised to wear a <a href="/wiki/Medical_identification_tag" title="Medical identification tag">medical identification tag</a> or carry a wallet card to alert those who may be providing emergency medical care of the urgent need for glucocorticoids.</p>
<h3><span class="mw-headline" id="Reconstructive_surgery">Reconstructive surgery</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=12" title="Edit section: Reconstructive surgery">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Surgery need never be considered for genetically male (XY) infants because the excess androgens do not produce anatomic abnormality. However, <a href="/wiki/Intersex_surgery" title="Intersex surgery">surgery</a> for severely virilized XX infants is often performed and has become a subject of <a href="/wiki/History_of_intersex_surgery" title="History of intersex surgery">debate</a> in the last decade.</p>
<p>Surgical reconstruction of abnormal genitalia has been offered to parents of severely virilized girls with CAH since the first half of the 20th century. The purposes of surgery have generally been a combination of the following:</p>
<ol>
<li>To make the external genitalia look more female than male</li>
<li>To make it possible for these girls to participate in normal <a href="/wiki/Sexual_intercourse" title="Sexual intercourse">sexual intercourse</a> when they grow up</li>
<li>To improve their chances of fertility</li>
<li>To reduce the frequency of urinary infections</li>
</ol>
<p>In the 1950s and 1960s, surgery often involved clitorectomy (removal of most of the clitoris), an operation that also reduced genital sensation. In the 1970s, new operative methods were developed to preserve innervation and clitoral function. However, a number of retrospective surveys in the last decade suggest that (1) sexual enjoyment is reduced in many women even after nerve-sparing procedures, and (2) women with CAH who have not had surgery also have a substantial rate of sexual dysfunction. (<i>See <a href="/wiki/Intersex_surgery" title="Intersex surgery">Intersex surgery</a> for an overview of procedures and potential complications, and <a href="/wiki/History_of_intersex_surgery" title="History of intersex surgery">History of intersex surgery</a> for a fuller discussion of the controversies.) Many patient advocates and surgeons argue for deferring surgery until adolescence or later, while some surgeons continue to argue that infant surgery has advantages.</i></p>
<h3><span class="mw-headline" id="Optimizing_growth_in_CAH">Optimizing growth in CAH</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=13" title="Edit section: Optimizing growth in CAH">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>One of the challenging aspects of long-term management is optimizing growth so that a child with CAH achieves his or her height potential because both undertreatment and overtreatment can reduce growth or the remaining time for growth. While glucocorticoids are essential for health, dosing is always a matter of approximation. In even mildly excessive amounts, glucocorticoids slow growth. On the other hand, adrenal androgens are readily converted to <a href="/wiki/Estradiol" title="Estradiol">estradiol</a>, which accelerates <a href="/wiki/Bone_age" title="Bone age">bone maturation</a> and can lead to early <a href="/wiki/Epiphysis" title="Epiphysis">epiphyseal</a> closure. This narrow target of optimal dose is made more difficult to obtain by the imperfect replication of normal diurnal plasma cortisol levels produced by 2 or 3 oral doses of hydrocortisone. As a consequence, average height losses of about 4&#160;inches (10&#160;cm) have been reported with traditional management.</p>
<p>Traditionally, pediatric endocrinologists have tried to optimize growth by measuring a child every few months to assess current rate of growth, by checking the <a href="/wiki/Bone_age" title="Bone age">bone age</a> every year or two, by periodically measuring <a href="/wiki/17OHP" title="17OHP" class="mw-redirect">17OHP</a> and <a href="/wiki/Testosterone" title="Testosterone">testosterone</a> levels as indicators of adrenal suppression, and by using hydrocortisone for glucocorticoid replacement rather than longer-acting <a href="/wiki/Prednisone" title="Prednisone">prednisone</a> or <a href="/wiki/Dexamethasone" title="Dexamethasone">dexamethasone</a>.</p>
<p>The growth problem is even worse in the simple virilizing forms of CAH which are detected when premature <a href="/wiki/Pubic_hair" title="Pubic hair">pubic hair</a> appears in childhood, because the <a href="/wiki/Bone_age" title="Bone age">bone age</a> is often several years advanced at the age of diagnosis. While a boy (or girl) with simple virilizing CAH is taller than peers at that point, he will have far fewer years remaining to grow, and may go from being a very tall 7-year-old to a 62-inch 13-year-old who has completed growth. Even with adrenal suppression, many of these children will have already had central <a href="/wiki/Precocious_puberty" title="Precocious puberty">precocious puberty</a> triggered by the prolonged exposure of the <a href="/wiki/Hypothalamus" title="Hypothalamus">hypothalamus</a> to the adrenal androgens and estrogens. If this has begun, it may be advantageous to suppress puberty with a <a href="/wiki/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone">gonadotropin-releasing hormone</a> agonist such as <a href="/wiki/Leuprolide" title="Leuprolide" class="mw-redirect">leuprolide</a> to slow continuing bone maturation.</p>
<p>In recent years some newer approaches to optimizing growth have been researched and are beginning to be used. It is possible to reduce the effects of androgens on the body by blocking the receptors with an antiandrogen such as <a href="/wiki/Flutamide" title="Flutamide">flutamide</a> and by reducing the conversion of testosterone to estradiol. This conversion is mediated by <a href="/wiki/Aromatase" title="Aromatase">aromatase</a> and can be inhibited by aromatase blockers such as <a href="/wiki/Testolactone" title="Testolactone">testolactone</a>. Blocking the effects and conversions of estrogens will allow use of lower doses of glucocorticoids with less risk of acceleration of bone maturation. Other proposed interventions have included bilateral adrenalectomy to remove the androgen sources, or <a href="/wiki/Growth_hormone_treatment" title="Growth hormone treatment">growth hormone treatment</a> to enhance growth.</p>
<p>For a more extensive review of the difficulties of optimizing growth, see Migeon CJ, Wisneiewski AB. Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency: growth, development, and therapeutic considerations. Endocrinol Metab Clin N Am 30:193-206, 2001.<sup id="cite_ref-pmid11344936_5-0" class="reference"><a href="#cite_note-pmid11344936-5"><span>[</span>5<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Preventing_hyperandrogenism_and_optimizing_fertility">Preventing hyperandrogenism and optimizing fertility</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=14" title="Edit section: Preventing hyperandrogenism and optimizing fertility">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>As growth ends, management in girls with CAH changes focus to optimizing reproductive function. Both excessive testosterone from the adrenals and excessive glucocorticoid treatment can disrupt <a href="/wiki/Ovulation" title="Ovulation">ovulation</a>, resulting in irregularity of <a href="/wiki/Menstrual_cycle" title="Menstrual cycle">menses</a> or <a href="/wiki/Amenorrhea" title="Amenorrhea" class="mw-redirect">amenorrhea</a>, as well as <a href="/wiki/Infertility" title="Infertility">infertility</a>. Continued monitoring of hormone balance and careful readjustment of glucocorticoid dose can usually restore fertility, but as a group, women with CAH have a lower fertility rate than a comparable population.</p>
<p>CAH has little effect on male fertility unless an adult stops taking his glucocorticoid medication entirely for an extended time, in which case excessive adrenal testosterone may reduce testicular production as well as spermatogenesis.</p>
<h3><span class="mw-headline" id="Psychosexual_development_and_issues">Psychosexual development and issues</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=15" title="Edit section: Psychosexual development and issues">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Nearly all <a href="/wiki/Mammal" title="Mammal">mammals</a> display <a href="/wiki/Sexual_dimorphism" title="Sexual dimorphism">sex-dimorphic</a> reproductive and sexual behavior (e.g., <a href="/wiki/Lordosis_behavior" title="Lordosis behavior">lordosis</a> and mounting in <a href="/wiki/Rodent" title="Rodent">rodents</a>). Much research has made it clear that prenatal and early postnatal androgens play a role in the differentiation of most mammalian brains. Experimental manipulation of androgen levels in utero or shortly after birth can alter adult reproductive behavior.</p>
<p>Girls and women with CAH constitute the majority of genetic females with normal internal reproductive hormones who have been exposed to male levels of testosterone throughout their prenatal lives. Milder degrees of continuing androgen exposure continue throughout childhood and adolescence as a consequence of the imperfections of current glucocorticoid treatment for CAH. The psychosexual development of these girls and women has been analyzed as evidence of the role of androgens in human sex-dimorphic behaviors.</p>
<p>Girls with CAH have repeatedly been reported to spend more time with "sex-atypical" toys and "rough-and-tumble" play than unaffected sisters. These differences continue into adolescent, as expressed in social behaviors, leisure activities, and career interests. Interest in babies and becoming mothers is significantly lower by most measures.</p>
<p>Cognitive effects are less clear, and reports have been contradictory. Two studies reported spatial abilities above the average for sisters and for girls in general. Other evidence in males with and without androgen deficiencies suggests that androgens may play a role in these aptitudes.</p>
<p>However, gender identity of girls and women with CAH is nearly always unequivocally female. Sexual orientation is more mixed, though the majority are heterosexual. In one study, 27% of women with CAH were rated as bisexual in their orientations. Abnormalities of body image due to the effects of the disease likely play a role in the sexual development of these women, and one cannot conclude that the androgens are the major determinant of their sexuality.</p>
<h3><span class="mw-headline" id="Newborn_screening">Newborn screening</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=16" title="Edit section: Newborn screening">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Conditions justifying <a href="/wiki/Newborn_screening" title="Newborn screening">newborn screening</a> for any disorder include (1) a simple test with an acceptable <a href="/wiki/Sensitivity_(tests)" title="Sensitivity (tests)" class="mw-redirect">sensitivity</a> and <a href="/wiki/Specificity_(tests)" title="Specificity (tests)" class="mw-redirect">specificity</a>, (2) a dire consequence if not diagnosed early, (3) an effective treatment if diagnosed, and (4) a frequency in the population high enough to justify the expense. In the last decade more states and countries are adopting newborn screening for salt-wasting CAH due to 21-hydroxylase deficiency, which leads to death in the first month of life if not recognized.</p>
<p>The salt-wasting form of CAH has an incidence of 1 in 15,000 births and is potentially fatal within a month if untreated. Steroid replacement is a simple, effective treatment. However, the screening test itself is less than perfect. While the <a href="/wiki/17-hydroxyprogesterone" title="17-hydroxyprogesterone" class="mw-redirect">17OHP</a> level is easy to measure and sensitive (rarely missing real cases), the test has a poorer specificity. Screening programs in the United States have reported that 99% of positive screens turn out to be false positives upon investigation of the infant. This is a higher rate of false positives than the screening tests for many other <a href="/wiki/Congenital_metabolic_disease" title="Congenital metabolic disease" class="mw-redirect">congenital metabolic diseases</a>.</p>
<p>When a positive result is detected, the infant must be referred to a pediatric endocrinologist to confirm or disprove the diagnosis. Since most infants with salt-wasting CAH become critically ill by 2 weeks of age, the evaluation must be done rapidly despite the high false positive rate.</p>
<p>Levels of <a href="/wiki/17-hydroxyprogesterone" title="17-hydroxyprogesterone" class="mw-redirect">17-hydroxyprogesterone</a>, <a href="/wiki/Androstenedione" title="Androstenedione">androstenedione</a>, and <a href="/wiki/Cortisol" title="Cortisol">cortisol</a> may play a role in screening.<sup id="cite_ref-pmid19390483_6-0" class="reference"><a href="#cite_note-pmid19390483-6"><span>[</span>6<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prenatal_diagnosis_and_treatment">Prenatal diagnosis and treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=17" title="Edit section: Prenatal diagnosis and treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="metadata plainlinks ambox ambox-content ambox-Unreferenced" role="presentation">
<tr>
<td class="mbox-image">
<div style="width:52px"><a href="/wiki/File:Question_book-new.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" width="50" height="39" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x" data-file-width="262" data-file-height="204" /></a></div>
</td>
<td class="mbox-text"><span class="mbox-text-span">This section <b>does not <a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources">cite</a> any <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">references or sources</a></b>. <span class="hide-when-compact">Please help improve this section by <a href="/wiki/Help:Introduction_to_referencing/1" title="Help:Introduction to referencing/1">adding citations to reliable sources</a>. Unsourced material may be challenged and <a href="/wiki/Wikipedia:Verifiability#Burden_of_evidence" title="Wikipedia:Verifiability">removed</a>.</span> <small><i>(September 2012)</i></small></span></td>
</tr>
</table>
<table class="metadata plainlinks ambox ambox-content ambox-POV" role="presentation">
<tr>
<td class="mbox-image">
<div style="width:52px"><img alt="Unbalanced scales.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Unbalanced_scales.svg/45px-Unbalanced_scales.svg.png" width="45" height="40" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Unbalanced_scales.svg/68px-Unbalanced_scales.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Unbalanced_scales.svg/90px-Unbalanced_scales.svg.png 2x" data-file-width="400" data-file-height="354" /></div>
</td>
<td class="mbox-text"><span class="mbox-text-span">The <b><a href="/wiki/Wikipedia:Neutral_point_of_view" title="Wikipedia:Neutral point of view">neutrality</a> of this section is <a href="/wiki/Wikipedia:NPOV_dispute" title="Wikipedia:NPOV dispute">disputed</a></b>. <span class="hide-when-compact">Relevant discussion may be found on the <a href="/wiki/Talk:Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency#.23" title="Talk:Congenital adrenal hyperplasia due to 21-hydroxylase deficiency">talk page</a>. Please do not remove this message until the <a href="/wiki/Wikipedia:NPOV_dispute#What_is_an_NPOV_dispute.3F" title="Wikipedia:NPOV dispute">dispute is resolved</a>.</span> <small><i>(September 2012)</i></small></span></td>
</tr>
</table>
<p>Since CAH is an <a href="/wiki/Autosomal_recessive" title="Autosomal recessive" class="mw-redirect">autosomal recessive</a> disease, most children with CAH are born to parents unaware of the risk and with no family history. Each child will have a 25% chance of being born with the disease. Families typically wish to minimize the degree of <a href="/wiki/Virilization" title="Virilization">virilization</a> of a girl. There is no known prenatal harm to a male fetus from CAH, so treatment can begin at birth.</p>
<p>Adrenal glands of female fetuses with CAH begin producing excess <a href="/wiki/Testosterone" title="Testosterone">testosterone</a> by the 9th week of gestation. The most important aspects of virilization (urogenital closure and phallic urethra) occur between 8 and 12 weeks. Theoretically, if enough <a href="/wiki/Glucocorticoid" title="Glucocorticoid">glucocorticoid</a> could be supplied to the fetus to reduce adrenal testosterone production by the 9th week, virilization could be prevented and the difficult decision about timing of <a href="/wiki/History_of_intersex_surgery" title="History of intersex surgery">surgery</a> avoided.</p>
<p>The challenge of preventing severe virilization of girls is twofold: detection of CAH at the beginning of the pregnancy, and delivery of an effective amount of glucocorticoid to the fetus without causing harm to the mother.</p>
<p>The first problem has not yet been entirely solved, but it has been shown that if <a href="/wiki/Dexamethasone" title="Dexamethasone">dexamethasone</a> is taken by a pregnant woman, enough can cross the placenta to suppress fetal adrenal function.</p>
<p>At present no program screens for risk in families who have not yet had a child with CAH. For families desiring to avoid virilization of a second child, the current strategy is to start dexamethasone as soon as a pregnancy has been confirmed even though at that point the chance that the pregnancy is a girl with CAH is only 12.5%. Dexamethasone is taken by the mother each day until it can be safely determined whether she is carrying an affected girl.</p>
<p>Whether the fetus is an affected girl can be determined by <a href="/wiki/Chorionic_villus_sampling" title="Chorionic villus sampling">chorionic villus sampling</a> at 9–11 weeks of gestation, or by <a href="/wiki/Amniocentesis" title="Amniocentesis">amniocentesis</a> at 15–18 weeks gestation. In each case the fetal sex can be determined quickly, and if the fetus is a male the dexamethasone can be discontinued. If female, fetal <a href="/wiki/DNA" title="DNA">DNA</a> is analyzed to see if she carries one of the known abnormal alleles of the <i>CYP21</i> gene. If so, dexamethasone is continued for the remainder of the pregnancy at a dose of about 1&#160;mg daily.</p>
<p>Most mothers who have followed this treatment plan have experienced at least mild <a href="/wiki/Cushing%27s_syndrome" title="Cushing's syndrome">cushingoid</a> effects from the glucocorticoid but have borne daughters whose genitalia are much less virilized.</p>
<h2><span class="mw-headline" id="Childhood-onset_.28simple_virilizing.29_CAH">Childhood-onset (simple virilizing) CAH</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=18" title="Edit section: Childhood-onset (simple virilizing) CAH">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Mutations that result in some residual 21-hydroxylase activity cause milder disease, traditionally termed <b>simple virilizing CAH</b> (SVCAH). In these children the <a href="/wiki/Mineralocorticoid" title="Mineralocorticoid">mineralocorticoid</a> deficiency is less significant and salt-wasting does not occur. However, genital ambiguities are possible.</p>
<h2><span class="mw-headline" id="Late_onset_.28nonclassical.29_CAH">Late onset (nonclassical) CAH</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=19" title="Edit section: Late onset (nonclassical) CAH">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The <a href="/wiki/Androgen" title="Androgen">androgen</a> excess is mild enough that <a href="/wiki/Virilization" title="Virilization">virilization</a> is not apparent or goes unrecognized at birth and in early childhood. However, androgen levels are above normal and slowly rise during childhood, producing noticeable effects between 2 and 9 years of age.</p>
<p>Appearance of <a href="/wiki/Pubic_hair" title="Pubic hair">pubic hair</a> in mid-childhood is the most common feature that leads to evaluation and diagnosis. Other accompanying features are likely to be tall stature and accelerated <a href="/wiki/Bone_age" title="Bone age">bone age</a> (often 3–5 years ahead). Often present are increased muscle mass, <a href="/wiki/Acne_vulgaris" title="Acne vulgaris">acne</a>, and adult <a href="/wiki/Body_odor" title="Body odor">body odor</a>. In boys the <a href="/wiki/Human_penis" title="Human penis">penis</a> will be enlarged. Mild <a href="/wiki/Clitoris" title="Clitoris">clitoral</a> enlargement may occur in girls, and sometimes a degree of prenatal virilization is recognized that may have gone unnoticed in infancy.</p>
<p>The principal goals of treatment of non-classical CAH are to preserve as much growth as possible and to prevent central <a href="/wiki/Precocious_puberty" title="Precocious puberty">precocious puberty</a> if it has not already been triggered. These are more difficult challenges than in CAH detected in infancy because moderate levels of <a href="/wiki/Androgen" title="Androgen">androgens</a> will have had several years to advance bone maturation and to trigger central <a href="/wiki/Puberty" title="Puberty">puberty</a> before the disease is detected.</p>
<p>A diagnosis of non-classical CAH is usually confirmed by discovering extreme elevations of <a href="/wiki/17-hydroxyprogesterone" title="17-hydroxyprogesterone" class="mw-redirect">17-hydroxyprogesterone</a> along with moderately high testosterone levels. A <a href="/wiki/ACTH" title="ACTH" class="mw-redirect">cosyntropin</a> stimulation test may be needed in mild cases, but usually the random levels of 17OHP are high enough to confirm the diagnosis.</p>
<p>The mainstay of treatment is suppression of adrenal testosterone production by a <a href="/wiki/Glucocorticoid" title="Glucocorticoid">glucocorticoid</a> such as <a href="/wiki/Hydrocortisone" title="Hydrocortisone" class="mw-redirect">hydrocortisone</a>. Mineralocorticoid is only added in cases where the plasma <a href="/wiki/Renin" title="Renin">renin</a> activity is high.</p>
<p>A third key aspect of management is suppression of central precocious puberty if it has begun. The usual clues to central puberty in boys are that the <a href="/wiki/Testes" title="Testes" class="mw-redirect">testes</a> are pubertal in size, or that testosterone remains elevated even when the 17OHP has been reduced toward normal. In girls central puberty is less often a problem, but breast development would be the main clue. Central precocious puberty is suppressed when appropriate by <a href="/wiki/Leuprolide" title="Leuprolide" class="mw-redirect">leuprolide</a>.</p>
<p>As outlined above, recent additions to treatment to preserve growth include <a href="/wiki/Aromatase" title="Aromatase">aromatase</a> inhibition to slow bone maturation by reducing the amount of testosterone converted to <a href="/wiki/Estradiol" title="Estradiol">estradiol</a>, and use of blockers of estrogen for the same purpose.</p>
<p>Once adrenal suppression has been achieved, the patient needs stress steroid coverage as described above for significant illness or injury.</p>
<p>Other alleles result in even milder degrees of hyperandrogenism that may not even cause problems in males and may not be recognized until adolescence or later in females. Mild androgen effects in young women may include <a href="/wiki/Hirsutism" title="Hirsutism">hirsutism</a>, acne, or <a href="/wiki/Anovulation" title="Anovulation">anovulation</a> (which in turn can cause <a href="/wiki/Infertility" title="Infertility">infertility</a>). Testosterone levels in these women may be mildly elevated, or simply above average. These clinical features, of course, are those of <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">polycystic ovary syndrome</a>, and a small percentage of women with <a href="/wiki/Polycystic_Ovary_Syndrome" title="Polycystic Ovary Syndrome" class="mw-redirect">Polycystic Ovary Syndrome(PCOS)</a> are found to have late-onset CAH when investigated.</p>
<p>Diagnosis of late-onset CAH may be suspected from a high 17-hydroxyprogesterone level, but some cases are so mild that the elevation is only demonstrable after <a href="/wiki/Cosyntropin" title="Cosyntropin" class="mw-redirect">cosyntropin</a> stimulation. Treatment may involve a combination of very low dose glucocorticoid to reduce adrenal androgen production and any of various agents to block the androgen effects and/or induce ovulation.</p>
<p>It was characterized in 1979 by Dr. <a href="/wiki/Maria_New" title="Maria New">Maria New</a>.<sup id="cite_ref-pmid15838095_7-0" class="reference"><a href="#cite_note-pmid15838095-7"><span>[</span>7<span>]</span></a></sup> Prevalence has been described as 1 in 100 in certain populations.<sup id="cite_ref-pmid16912124_8-0" class="reference"><a href="#cite_note-pmid16912124-8"><span>[</span>8<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=20" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/Inborn_errors_of_steroid_metabolism" title="Inborn errors of steroid metabolism">Inborn errors of steroid metabolism</a></li>
<li><a href="/wiki/Congenital_adrenal_hyperplasia" title="Congenital adrenal hyperplasia">Congenital adrenal hyperplasia</a></li>
<li><a href="/wiki/Adrenal_insufficiency" title="Adrenal insufficiency">Adrenal insufficiency</a></li>
<li><a href="/wiki/Disorders_of_sexual_development" title="Disorders of sexual development" class="mw-redirect">Disorders of sexual development</a></li>
<li><a href="/wiki/Intersex" title="Intersex">Intersexuality</a>, <a href="/wiki/Pseudohermaphroditism" title="Pseudohermaphroditism">pseudohermaphroditism</a>, and <a href="/wiki/Ambiguous_genitalia" title="Ambiguous genitalia" class="mw-redirect">ambiguous genitalia</a></li>
<li><a href="/wiki/21-Hydroxylase" title="21-Hydroxylase">21-Hydroxylase</a></li>
</ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=21" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 33em; -webkit-column-width: 33em; column-width: 33em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-pmid10857554-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10857554_1-0">^</a></b></span> <span class="reference-text"><span class="citation journal">White PC, Speiser PW (June 2000). <a rel="nofollow" class="external text" href="http://edrv.endojournals.org/cgi/pmidlookup?view=long&amp;pmid=10857554">"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency"</a>. <i>Endocr. Rev.</i> <b>21</b> (3): 245–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1210%2Fer.21.3.245">10.1210/er.21.3.245</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10857554">10857554</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACongenital+adrenal+hyperplasia+due+to+21-hydroxylase+deficiency&amp;rft.atitle=Congenital+adrenal+hyperplasia+due+to+21-hydroxylase+deficiency&amp;rft.aulast=White+PC%2C+Speiser+PW&amp;rft.au=White+PC%2C+Speiser+PW&amp;rft.date=June+2000&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fedrv.endojournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D10857554&amp;rft_id=info%3Adoi%2F10.1210%2Fer.21.3.245&amp;rft_id=info%3Apmid%2F10857554&amp;rft.issue=3&amp;rft.jtitle=Endocr.+Rev.&amp;rft.pages=245-91&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15988383-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15988383_2-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Forest MG, Tardy V, Nicolino M, David M, Morel Y (June 2005). <a rel="nofollow" class="external text" href="http://www.masson.fr/masson/MDOI-AE-06-2005-66-3-0003-4266-101019-200502457">"21-Hydroxylase deficiency: an exemplary model of the contribution of molecular biology in the understanding and management of the disease"</a>. <i>Ann. Endocrinol. (Paris)</i> <b>66</b> (3): 225–32. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fs0003-4266%2805%2981754-8">10.1016/s0003-4266(05)81754-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15988383">15988383</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACongenital+adrenal+hyperplasia+due+to+21-hydroxylase+deficiency&amp;rft.atitle=21-Hydroxylase+deficiency%3A+an+exemplary+model+of+the+contribution+of+molecular+biology+in+the+understanding+and+management+of+the+disease&amp;rft.au=Forest+MG%2C+Tardy+V%2C+Nicolino+M%2C+David+M%2C+Morel+Y&amp;rft.aulast=Forest+MG%2C+Tardy+V%2C+Nicolino+M%2C+David+M%2C+Morel+Y&amp;rft.date=June+2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.masson.fr%2Fmasson%2FMDOI-AE-06-2005-66-3-0003-4266-101019-200502457&amp;rft_id=info%3Adoi%2F10.1016%2Fs0003-4266%2805%2981754-8&amp;rft_id=info%3Apmid%2F15988383&amp;rft.issue=3&amp;rft.jtitle=Ann.+Endocrinol.+%28Paris%29&amp;rft.pages=225-32&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=66" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19228439-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19228439_3-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Trakakis E, Loghis C, Kassanos D (March 2009). "Congenital adrenal hyperplasia because of 21-hydroxylase deficiency. A genetic disorder of interest to obstetricians and gynecologists". <i>Obstet Gynecol Surv</i> <b>64</b> (3): 177–89. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2FOGX.0b013e318193301b">10.1097/OGX.0b013e318193301b</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19228439">19228439</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACongenital+adrenal+hyperplasia+due+to+21-hydroxylase+deficiency&amp;rft.atitle=Congenital+adrenal+hyperplasia+because+of+21-hydroxylase+deficiency.+A+genetic+disorder+of+interest+to+obstetricians+and+gynecologists&amp;rft.aulast=Trakakis+E%2C+Loghis+C%2C+Kassanos+D&amp;rft.au=Trakakis+E%2C+Loghis+C%2C+Kassanos+D&amp;rft.date=March+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FOGX.0b013e318193301b&amp;rft_id=info%3Apmid%2F19228439&amp;rft.issue=3&amp;rft.jtitle=Obstet+Gynecol+Surv&amp;rft.pages=177-89&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=64" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><span class="citation journal">Martinez-Aguayo, A; Rocha, A; Rojas, N; García, C; Parra, R; Lagos, M; Valdivia, L; Poggi, H et al. (2007). "Testicular adrenal rest tumors and Leydig and Sertoli cell function in boys with classical congenital adrenal hyperplasia". <i>The Journal of Clinical Endocrinology and Metabolism</i> <b>92</b> (12): 4583–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1210%2Fjc.2007-0383">10.1210/jc.2007-0383</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17895312">17895312</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACongenital+adrenal+hyperplasia+due+to+21-hydroxylase+deficiency&amp;rft.atitle=Testicular+adrenal+rest+tumors+and+Leydig+and+Sertoli+cell+function+in+boys+with+classical+congenital+adrenal+hyperplasia&amp;rft.au=Cattani%2C+A&amp;rft.au=Chilean+Collaborative+Testicular+Adrenal+Rest+Tumor+Study+Group&amp;rft.aufirst=A&amp;rft.au=Garc%C3%ADa%2C+C&amp;rft.au=Lagos%2C+M&amp;rft.aulast=Martinez-Aguayo&amp;rft.au=Martinez-Aguayo%2C+A&amp;rft.au=Parra%2C+R&amp;rft.au=Poggi%2C+H&amp;rft.au=Rocha%2C+A&amp;rft.au=Rojas%2C+N&amp;rft.au=Valdivia%2C+L&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1210%2Fjc.2007-0383&amp;rft_id=info%3Apmid%2F17895312&amp;rft.issue=12&amp;rft.jtitle=The+Journal+of+Clinical+Endocrinology+and+Metabolism&amp;rft.pages=4583-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=92" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11344936-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11344936_5-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Migeon CJ, Wisniewski AB (March 2001). "Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Growth, development, and therapeutic considerations". <i>Endocrinol. Metab. Clin. North Am.</i> <b>30</b> (1): 193–206. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0889-8529%2808%2970026-4">10.1016/S0889-8529(08)70026-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11344936">11344936</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACongenital+adrenal+hyperplasia+due+to+21-hydroxylase+deficiency&amp;rft.atitle=Congenital+adrenal+hyperplasia+owing+to+21-hydroxylase+deficiency.+Growth%2C+development%2C+and+therapeutic+considerations&amp;rft.aulast=Migeon+CJ%2C+Wisniewski+AB&amp;rft.au=Migeon+CJ%2C+Wisniewski+AB&amp;rft.date=March+2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0889-8529%2808%2970026-4&amp;rft_id=info%3Apmid%2F11344936&amp;rft.issue=1&amp;rft.jtitle=Endocrinol.+Metab.+Clin.+North+Am.&amp;rft.pages=193-206&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19390483-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19390483_6-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Schwarz E, Liu A, Randall H et al. (April 2009). "Use of Steroid Profiling by UPLC-MS/MS as a Second Tier Test in Newborn Screening for Congenital Adrenal Hyperplasia: the Utah experience". <i>Pediatr. Res.</i> <b>66</b> (2): 230–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1203%2FPDR.0b013e3181aa3777">10.1203/PDR.0b013e3181aa3777</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19390483">19390483</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACongenital+adrenal+hyperplasia+due+to+21-hydroxylase+deficiency&amp;rft.atitle=Use+of+Steroid+Profiling+by+UPLC-MS%2FMS+as+a+Second+Tier+Test+in+Newborn+Screening+for+Congenital+Adrenal+Hyperplasia%3A+the+Utah+experience&amp;rft.aulast=Schwarz+E%2C+Liu+A%2C+Randall+H&amp;rft.au=Schwarz+E%2C+Liu+A%2C+Randall+H&amp;rft.date=April+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1203%2FPDR.0b013e3181aa3777&amp;rft_id=info%3Apmid%2F19390483&amp;rft.issue=2&amp;rft.jtitle=Pediatr.+Res.&amp;rft.pages=230-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=66" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15838095-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15838095_7-0">^</a></b></span> <span class="reference-text"><span class="citation journal">New MI (December 2004). <a rel="nofollow" class="external text" href="http://www3.interscience.wiley.com/resolve/openurl?genre=article&amp;sid=nlm:pubmed&amp;issn=0077-8923&amp;date=2004&amp;volume=1038&amp;spage=14">"An update of congenital adrenal hyperplasia"</a>. <i>Ann. N. Y. Acad. Sci.</i> <b>1038</b>: 14–43. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1196%2Fannals.1315.009">10.1196/annals.1315.009</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15838095">15838095</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACongenital+adrenal+hyperplasia+due+to+21-hydroxylase+deficiency&amp;rft.atitle=An+update+of+congenital+adrenal+hyperplasia&amp;rft.aulast=New+MI&amp;rft.au=New+MI&amp;rft.date=December+2004&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww3.interscience.wiley.com%2Fresolve%2Fopenurl%3Fgenre%3Darticle%26sid%3Dnlm%3Apubmed%26issn%3D0077-8923%26date%3D2004%26volume%3D1038%26spage%3D14&amp;rft_id=info%3Adoi%2F10.1196%2Fannals.1315.009&amp;rft_id=info%3Apmid%2F15838095&amp;rft.jtitle=Ann.+N.+Y.+Acad.+Sci.&amp;rft.pages=14-43&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1038" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16912124-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16912124_8-0">^</a></b></span> <span class="reference-text"><span class="citation journal">New MI (November 2006). <a rel="nofollow" class="external text" href="http://jcem.endojournals.org/cgi/pmidlookup?view=long&amp;pmid=16912124">"Extensive clinical experience: nonclassical 21-hydroxylase deficiency"</a>. <i>J. Clin. Endocrinol. Metab.</i> <b>91</b> (11): 4205–14. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1210%2Fjc.2006-1645">10.1210/jc.2006-1645</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16912124">16912124</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACongenital+adrenal+hyperplasia+due+to+21-hydroxylase+deficiency&amp;rft.atitle=Extensive+clinical+experience%3A+nonclassical+21-hydroxylase+deficiency&amp;rft.aulast=New+MI&amp;rft.au=New+MI&amp;rft.date=November+2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjcem.endojournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D16912124&amp;rft_id=info%3Adoi%2F10.1210%2Fjc.2006-1645&amp;rft_id=info%3Apmid%2F16912124&amp;rft.issue=11&amp;rft.jtitle=J.+Clin.+Endocrinol.+Metab.&amp;rft.pages=4205-14&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=91" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit&amp;section=22" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&amp;part=cah">GeneReviews/NCBI/NIH/UW entry on 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia</a></li>
<li><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/omim/201910">OMIM entry on 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia</a></li>
<li><a rel="nofollow" class="external text" href="http://www.caresfoundation.org">CARES Foundation: Congenital Adrenal Research, Education, and Support</a></li>
<li><a rel="nofollow" class="external text" href="http://congenitaladrenalhyperplasia.org">CongenitalAdrenalHyperplasia.org</a></li>
<li><a rel="nofollow" class="external text" href="http://www.dshs.state.tx.us/newborn/cah.shtm">Texas Department of Health, Congenital Adrenal Hyperplasia</a></li>
<li><a rel="nofollow" class="external text" href="http://www.hopkinsmedicine.org/pediatricendocrinology/cah/index.html">Guide to Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency for parents or patients from Johns Hopkins</a></li>
<li><a rel="nofollow" class="external text" href="http://www.endotext.org/pediatrics/pediatrics8a/pediatricsframe8a.htm">A more advanced discussion of 21-hydroxylase deficiency by an eminent researcher of the disease.</a></li>
<li><a rel="nofollow" class="external text" href="http://www.aboutkidshealth.ca/EN/HOWTHEBODYWORKS/SEXDEVELOPMENTANOVERVIEW/CONGENITALADRENALHYPERPLASIACAH/Pages/ThePraderScale.aspx">Interactive animation of the Prader scale</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Endocrine_pathology" title="Template:Endocrine pathology"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Endocrine_pathology" title="Template talk:Endocrine pathology"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Endocrine_pathology&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Diseases of the <a href="/wiki/Endocrinology" title="Endocrinology">endocrine</a> system (<a href="/wiki/ICD-10_Chapter_IV:_Endocrine,_nutritional_and_metabolic_diseases#E00.E2.80.93E35_.E2.80.93_Endocrine_diseases" title="ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases">E00–E35</a>, <a href="/wiki/List_of_ICD-9_codes_240%E2%80%93279:_endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders#Disorders_of_thyroid_gland_.28240.E2.80.93246.29" title="List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders">240–259</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Pancreatic_disease" title="Pancreatic disease">Pancreas</a>/<br />
<a href="/wiki/Glucose_metabolism_disorder" title="Glucose metabolism disorder" class="mw-redirect">glucose<br />
metabolism</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">Hypofunction</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">Diabetes mellitus</a></li>
</ul>
<ul>
<li><i>types:</i>
<ul>
<li><a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">type 1</a></li>
<li><a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">type 2</a></li>
<li><a href="/wiki/Maturity_onset_diabetes_of_the_young" title="Maturity onset diabetes of the young">MODY</a> <a href="/wiki/MODY_1" title="MODY 1">1</a> <a href="/wiki/MODY_2" title="MODY 2">2</a> <a href="/wiki/MODY_3" title="MODY 3">3</a> <a href="/wiki/MODY_4" title="MODY 4">4</a> <a href="/wiki/MODY_5" title="MODY 5">5</a> <a href="/wiki/MODY_6" title="MODY 6">6</a></li>
</ul>
</li>
<li><i><a href="/wiki/Complications_of_diabetes_mellitus" title="Complications of diabetes mellitus">complications</a></i>
<ul>
<li><a href="/wiki/Diabetic_coma" title="Diabetic coma">coma</a></li>
<li><a href="/wiki/Diabetic_angiopathy" title="Diabetic angiopathy">angiopathy</a></li>
<li><a href="/wiki/Diabetic_ketoacidosis" title="Diabetic ketoacidosis">ketoacidosis</a></li>
<li><a href="/wiki/Diabetic_nephropathy" title="Diabetic nephropathy">nephropathy</a></li>
<li><a href="/wiki/Diabetic_neuropathy" title="Diabetic neuropathy">neuropathy</a></li>
<li><a href="/wiki/Diabetic_retinopathy" title="Diabetic retinopathy">retinopathy</a></li>
<li><a href="/wiki/Diabetic_cardiomyopathy" title="Diabetic cardiomyopathy">cardiomyopathy</a></li>
</ul>
</li>
</ul>
<ul>
<li><i>insulin receptor</i> (<a href="/wiki/Rabson%E2%80%93Mendenhall_syndrome" title="Rabson–Mendenhall syndrome">Rabson–Mendenhall syndrome</a>)</li>
<li><a href="/wiki/Insulin_resistance" title="Insulin resistance">Insulin resistance</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Hyperfunction</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hypoglycemia" title="Hypoglycemia">Hypoglycemia</a></li>
<li><i><a href="/wiki/Beta_cell" title="Beta cell">beta cell</a></i> (<a href="/wiki/Hyperinsulinism" title="Hyperinsulinism">Hyperinsulinism</a>)</li>
<li><i><a href="/wiki/G_cell" title="G cell">G cell</a></i> (<a href="/wiki/Zollinger%E2%80%93Ellison_syndrome" title="Zollinger–Ellison syndrome">Zollinger–Ellison syndrome</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypothalamic" title="Hypothalamic" class="mw-redirect">Hypothalamic</a>/<br />
<a href="/wiki/Pituitary" title="Pituitary" class="mw-redirect">pituitary</a> axes</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypothalamic_disease" title="Hypothalamic disease">Hypothalamus</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Gonadotropin" title="Gonadotropin">gonadotropin</a></i>
<ul>
<li><a href="/wiki/Kallmann_syndrome" title="Kallmann syndrome">Kallmann syndrome</a></li>
<li><a href="/wiki/Adiposogenital_dystrophy" title="Adiposogenital dystrophy">Adiposogenital dystrophy</a></li>
</ul>
</li>
<li><i><a href="/wiki/Corticotropin-releasing_hormone" title="Corticotropin-releasing hormone">CRH</a></i> (<a href="/wiki/Adrenal_insufficiency" title="Adrenal insufficiency">Tertiary adrenal insufficiency</a>)</li>
<li><i><a href="/wiki/Vasopressin" title="Vasopressin">vasopressin</a></i> (<a href="/wiki/Neurogenic_diabetes_insipidus" title="Neurogenic diabetes insipidus">Neurogenic diabetes insipidus</a>)</li>
<li><i>general</i> (<a href="/wiki/Hypothalamic_hamartoma" title="Hypothalamic hamartoma" class="mw-redirect">Hypothalamic hamartoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Pituitary_disease" title="Pituitary disease">Pituitary</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hyperpituitarism" title="Hyperpituitarism">Hyperpituitarism</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>anterior</i>
<ul>
<li><a href="/wiki/Acromegaly" title="Acromegaly">Acromegaly</a></li>
<li><a href="/wiki/Hyperprolactinaemia" title="Hyperprolactinaemia">Hyperprolactinaemia</a></li>
<li><a href="/wiki/Pituitary_ACTH_hypersecretion" title="Pituitary ACTH hypersecretion">Pituitary ACTH hypersecretion</a></li>
</ul>
</li>
<li><i>posterior</i> (<a href="/wiki/Syndrome_of_inappropriate_antidiuretic_hormone" title="Syndrome of inappropriate antidiuretic hormone" class="mw-redirect">SIADH</a>)</li>
<li><i>general</i> (<a href="/wiki/Nelson%27s_syndrome" title="Nelson's syndrome">Nelson's syndrome</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypopituitarism" title="Hypopituitarism">Hypopituitarism</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>anterior</i>
<ul>
<li><a href="/wiki/Kallmann_syndrome" title="Kallmann syndrome">Kallmann syndrome</a></li>
<li><a href="/wiki/Growth_hormone_deficiency" title="Growth hormone deficiency">Growth hormone deficiency</a></li>
<li><a href="/wiki/Hypoprolactinemia" title="Hypoprolactinemia">Hypoprolactinemia</a></li>
<li><a href="/wiki/Adrenocorticotropic_hormone_deficiency" title="Adrenocorticotropic hormone deficiency">ACTH deficiency</a>/<a href="/wiki/Adrenal_insufficiency" title="Adrenal insufficiency">Secondary adrenal insufficiency</a></li>
<li><a href="/wiki/Gonadotropin-releasing_hormone_insensitivity" title="Gonadotropin-releasing hormone insensitivity">GnRH insensitivity</a></li>
<li><a href="/wiki/Follicle-stimulating_hormone_insensitivity" title="Follicle-stimulating hormone insensitivity">FSH insensitivity</a></li>
<li><a href="/wiki/Luteinizing_hormone_insensitivity" title="Luteinizing hormone insensitivity" class="mw-redirect">LH/hCG insensitivity</a></li>
</ul>
</li>
<li><i>posterior</i> (<a href="/wiki/Neurogenic_diabetes_insipidus" title="Neurogenic diabetes insipidus">Neurogenic</a> <a href="/wiki/Diabetes_insipidus" title="Diabetes insipidus">diabetes insipidus</a>)</li>
<li><i>general</i>
<ul>
<li><a href="/wiki/Empty_sella_syndrome" title="Empty sella syndrome">Empty sella syndrome</a></li>
<li><a href="/wiki/Pituitary_apoplexy" title="Pituitary apoplexy">Pituitary apoplexy</a></li>
<li><a href="/wiki/Sheehan%27s_syndrome" title="Sheehan's syndrome">Sheehan's syndrome</a></li>
<li><a href="/wiki/Lymphocytic_hypophysitis" title="Lymphocytic hypophysitis" class="mw-redirect">Lymphocytic hypophysitis</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Thyroid_disease" title="Thyroid disease">Thyroid</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypothyroidism" title="Hypothyroidism">Hypothyroidism</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Iodine_deficiency" title="Iodine deficiency">Iodine deficiency</a></li>
<li><a href="/wiki/Cretinism" title="Cretinism">Cretinism</a>
<ul>
<li><a href="/wiki/Congenital_hypothyroidism" title="Congenital hypothyroidism">Congenital hypothyroidism</a></li>
</ul>
</li>
<li><a href="/wiki/Myxedema" title="Myxedema">Myxedema</a></li>
<li><a href="/wiki/Euthyroid_sick_syndrome" title="Euthyroid sick syndrome">Euthyroid sick syndrome</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hyperthyroidism" title="Hyperthyroidism">Hyperthyroidism</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hyperthyroxinemia" title="Hyperthyroxinemia">Hyperthyroxinemia</a>
<ul>
<li><a href="/wiki/Thyroid_hormone_resistance" title="Thyroid hormone resistance">Thyroid hormone resistance</a></li>
<li><a href="/wiki/Familial_dysalbuminemic_hyperthyroxinemia" title="Familial dysalbuminemic hyperthyroxinemia">Familial dysalbuminemic hyperthyroxinemia</a></li>
</ul>
</li>
<li><a href="/wiki/Hashitoxicosis" title="Hashitoxicosis">Hashitoxicosis</a></li>
<li><a href="/wiki/Thyrotoxicosis_factitia" title="Thyrotoxicosis factitia">Thyrotoxicosis factitia</a></li>
<li><a href="/wiki/Graves%27_disease" title="Graves' disease">Graves' disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Thyroiditis" title="Thyroiditis">Thyroiditis</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_infectious_thyroiditis" title="Acute infectious thyroiditis">Acute infectious</a></li>
<li><a href="/wiki/Subacute_thyroiditis" title="Subacute thyroiditis">Subacute</a>
<ul>
<li><a href="/wiki/De_Quervain%27s_thyroiditis" title="De Quervain's thyroiditis">De Quervain's</a></li>
<li><a href="/wiki/Subacute_lymphocytic_thyroiditis" title="Subacute lymphocytic thyroiditis">Subacute lymphocytic</a></li>
</ul>
</li>
<li><a href="/wiki/Autoimmune_thyroiditis" title="Autoimmune thyroiditis">Autoimmune</a>/chronic
<ul>
<li><a href="/wiki/Hashimoto%27s_thyroiditis" title="Hashimoto's thyroiditis">Hashimoto's</a></li>
<li><a href="/wiki/Postpartum_thyroiditis" title="Postpartum thyroiditis">Postpartum</a></li>
<li><a href="/wiki/Riedel%27s_thyroiditis" title="Riedel's thyroiditis">Riedel's</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Goitre" title="Goitre">Goitre</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Endemic_goitre" title="Endemic goitre">Endemic goitre</a></li>
<li><a href="/wiki/Toxic_nodular_goitre" title="Toxic nodular goitre" class="mw-redirect">Toxic nodular goitre</a></li>
<li><a href="/wiki/Toxic_multinodular_goiter" title="Toxic multinodular goiter" class="mw-redirect">Toxic multinodular goiter</a></li>
</ul>
<ul>
<li><a href="/wiki/Thyroid_nodule" title="Thyroid nodule">Thyroid nodule</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Parathyroid_disease" title="Parathyroid disease">Parathyroid</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypoparathyroidism" title="Hypoparathyroidism">Hypoparathyroidism</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hypoparathyroidism" title="Hypoparathyroidism">Hypoparathyroidism</a></li>
<li><a href="/wiki/Pseudohypoparathyroidism" title="Pseudohypoparathyroidism">Pseudohypoparathyroidism</a></li>
<li><a href="/wiki/Pseudopseudohypoparathyroidism" title="Pseudopseudohypoparathyroidism">Pseudopseudohypoparathyroidism</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hyperparathyroidism" title="Hyperparathyroidism">Hyperparathyroidism</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Primary_hyperparathyroidism" title="Primary hyperparathyroidism">Primary</a></li>
<li><a href="/wiki/Secondary_hyperparathyroidism" title="Secondary hyperparathyroidism">Secondary</a></li>
<li><a href="/wiki/Tertiary_hyperparathyroidism" title="Tertiary hyperparathyroidism">Tertiary</a></li>
<li><a href="/wiki/Osteitis_fibrosa_cystica" title="Osteitis fibrosa cystica">Osteitis fibrosa cystica</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Adrenal_gland_disorder" title="Adrenal gland disorder">Adrenal</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Adrenocortical_hyperfunction" title="Adrenocortical hyperfunction">Hyperfunction</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Aldosterone" title="Aldosterone">aldosterone</a>:</i> <a href="/wiki/Hyperaldosteronism" title="Hyperaldosteronism">Hyperaldosteronism</a>/<a href="/wiki/Primary_aldosteronism" title="Primary aldosteronism">Primary aldosteronism</a>
<ul>
<li><a href="/wiki/Conn_syndrome" title="Conn syndrome" class="mw-redirect">Conn syndrome</a></li>
<li><a href="/wiki/Bartter_syndrome" title="Bartter syndrome">Bartter syndrome</a></li>
<li><a href="/wiki/Glucocorticoid_remediable_aldosteronism" title="Glucocorticoid remediable aldosteronism">Glucocorticoid remediable aldosteronism</a></li>
</ul>
</li>
<li><a href="/wiki/Apparent_mineralocorticoid_excess_syndrome" title="Apparent mineralocorticoid excess syndrome">AME</a></li>
<li><a href="/wiki/Liddle%27s_syndrome" title="Liddle's syndrome">Liddle's syndrome</a></li>
<li><a href="/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency">17α CAH</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Cortisol" title="Cortisol">cortisol</a>:</i> <a href="/wiki/Cushing%27s_syndrome" title="Cushing's syndrome">Cushing's syndrome</a> (<a href="/wiki/Pseudo-Cushing%27s_syndrome" title="Pseudo-Cushing's syndrome">Pseudo-Cushing's syndrome</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Sex_hormone" title="Sex hormone" class="mw-redirect">sex hormones</a>:</i> <strong class="selflink">21α CAH</strong></li>
<li><a href="/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency">11β CAH</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Hypofunction/<br />
<a href="/wiki/Adrenal_insufficiency" title="Adrenal insufficiency">Adrenal insufficiency</a><br />
(<a href="/wiki/Addison%27s_disease" title="Addison's disease">Addison's</a>, <a href="/wiki/Waterhouse-Friderichsen_syndrome" title="Waterhouse-Friderichsen syndrome" class="mw-redirect">WF</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>aldosterone:</i> <a href="/wiki/Hypoaldosteronism" title="Hypoaldosteronism">Hypoaldosteronism</a>
<ul>
<li><strong class="selflink">21α CAH</strong></li>
<li><a href="/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency">11β CAH</a></li>
</ul>
</li>
</ul>
<ul>
<li><i>cortisol:</i> <a href="/wiki/Congenital_adrenal_hyperplasia" title="Congenital adrenal hyperplasia">CAH</a>
<ul>
<li><a href="/wiki/Lipoid_congenital_adrenal_hyperplasia" title="Lipoid congenital adrenal hyperplasia">Lipoid</a></li>
<li><a href="/wiki/Congenital_adrenal_hyperplasia_due_to_3_beta-hydroxysteroid_dehydrogenase_deficiency" title="Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency">3β</a></li>
<li><a href="/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency">11β</a></li>
<li><a href="/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency">17α</a></li>
<li><strong class="selflink">21α</strong></li>
</ul>
</li>
</ul>
<ul>
<li><i>sex hormones:</i> <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency">17α CAH</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Gonadal_disorder" title="Gonadal disorder" class="mw-redirect">Gonads</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Ovarian_disease" title="Ovarian disease">ovarian</a>:</i> <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">Polycystic ovary syndrome</a></li>
<li><a href="/wiki/Premature_ovarian_failure" title="Premature ovarian failure">Premature ovarian failure</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Testicular_disease" title="Testicular disease">testicular</a>: enzymatic</i>
<ul>
<li><a href="/wiki/5%CE%B1-reductase_deficiency" title="5α-reductase deficiency" class="mw-redirect">5α-reductase deficiency</a></li>
<li><a href="/wiki/17%CE%B2-hydroxysteroid_dehydrogenase_deficiency" title="17β-hydroxysteroid dehydrogenase deficiency" class="mw-redirect">17β-hydroxysteroid dehydrogenase deficiency</a></li>
<li><a href="/wiki/Aromatase_excess_syndrome" title="Aromatase excess syndrome">aromatase excess syndrome</a>)</li>
</ul>
</li>
<li><i><a href="/wiki/Androgen_receptor" title="Androgen receptor">Androgen receptor</a></i> (<a href="/wiki/Androgen_insensitivity_syndrome" title="Androgen insensitivity syndrome">Androgen insensitivity syndrome</a>)</li>
</ul>
<ul>
<li><i>general:</i> <a href="/wiki/Hypogonadism" title="Hypogonadism">Hypogonadism</a> (<a href="/wiki/Delayed_puberty" title="Delayed puberty">Delayed puberty</a>)</li>
<li><a href="/wiki/Hypergonadism" title="Hypergonadism">Hypergonadism</a>
<ul>
<li><a href="/wiki/Precocious_puberty" title="Precocious puberty">Precocious puberty</a></li>
</ul>
</li>
<li><a href="/wiki/Hypoandrogenism" title="Hypoandrogenism" class="mw-redirect">Hypoandrogenism</a></li>
<li><a href="/wiki/Hypoestrogenism" title="Hypoestrogenism">Hypoestrogenism</a></li>
<li><a href="/wiki/Hyperandrogenism" title="Hyperandrogenism">Hyperandrogenism</a></li>
<li><a href="/wiki/Hyperestrogenism" title="Hyperestrogenism">Hyperestrogenism</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Height</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Dwarfism" title="Dwarfism">Dwarfism</a>/<a href="/wiki/Short_stature" title="Short stature">Short stature</a>
<ul>
<li><a href="/wiki/Midget" title="Midget">Midget</a></li>
<li><a href="/wiki/Laron_syndrome" title="Laron syndrome">Laron syndrome</a></li>
<li><a href="/wiki/Psychosocial_short_stature" title="Psychosocial short stature">Psychosocial</a></li>
<li><a href="/wiki/Ateliosis" title="Ateliosis">Ateliosis</a></li>
</ul>
</li>
<li><a href="/wiki/Gigantism" title="Gigantism">Gigantism</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Multiple</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/w/index.php?title=Autoimmune_polyendocrine_syndrome_multiple&amp;action=edit&amp;redlink=1" class="new" title="Autoimmune polyendocrine syndrome multiple (page does not exist)">Autoimmune polyendocrine syndrome multiple</a>
<ul>
<li><a href="/wiki/Autoimmune_polyendocrine_syndrome_type_1" title="Autoimmune polyendocrine syndrome type 1">APS1</a></li>
<li><a href="/wiki/Autoimmune_polyendocrine_syndrome_type_2" title="Autoimmune polyendocrine syndrome type 2">APS2</a></li>
</ul>
</li>
<li><a href="/wiki/Carcinoid_syndrome" title="Carcinoid syndrome">Carcinoid syndrome</a></li>
<li><a href="/wiki/Multiple_endocrine_neoplasia" title="Multiple endocrine neoplasia">Multiple endocrine neoplasia</a>
<ul>
<li><a href="/wiki/Multiple_endocrine_neoplasia_type_1" title="Multiple endocrine neoplasia type 1">1</a></li>
<li><a href="/wiki/Multiple_endocrine_neoplasia_type_2" title="Multiple endocrine neoplasia type 2">2A</a></li>
<li><a href="/wiki/Multiple_endocrine_neoplasia_type_2b" title="Multiple endocrine neoplasia type 2b">2B</a></li>
</ul>
</li>
<li><a href="/wiki/Progeria" title="Progeria">Progeria</a>
<ul>
<li><a href="/wiki/Werner_syndrome" title="Werner syndrome">Werner syndrome</a></li>
<li><a href="/wiki/Acrogeria" title="Acrogeria">Acrogeria</a></li>
<li><a href="/wiki/Metageria" title="Metageria">Metageria</a></li>
</ul>
</li>
<li><a href="/wiki/Woodhouse-Sakati_syndrome" title="Woodhouse-Sakati syndrome" class="mw-redirect">Woodhouse-Sakati syndrome</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Endocrine_navs" title="Template:Endocrine navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Endocrine_navs" title="Template talk:Endocrine navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Endocrine_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Endocrine_system" title="Endocrine system">hormones</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Endocrine_system_anatomy" title="Template:Endocrine system anatomy">Glands</a></li>
<li><a href="/wiki/Template:Hormones" title="Template:Hormones">Hormones</a>
<ul>
<li>thyroid
<ul>
<li><i><a href="/wiki/Template:Thyroid_hormone_intermediates" title="Template:Thyroid hormone intermediates">intermediates</a></i></li>
<li><i><a href="/wiki/Template:Thyroid_hormone_metabolism_enzymes_and_transporters" title="Template:Thyroid hormone metabolism enzymes and transporters">metabolism</a></i></li>
</ul>
</li>
<li><a href="/wiki/Template:Mineralocorticoids" title="Template:Mineralocorticoids">mineralocorticoids</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Endocrinology_physiology" title="Template:Endocrinology physiology">Physiology</a></li>
<li><a href="/wiki/Template:Development_of_endocrine_system" title="Template:Development of endocrine system">Development</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Diabetes" title="Template:Diabetes">Diabetes</a></li>
<li><a href="/wiki/Template:Congenital_endocrine_disorders" title="Template:Congenital endocrine disorders">Congenital</a></li>
<li><a href="/wiki/Template:Endocrine_gland_neoplasia" title="Template:Endocrine gland neoplasia">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Endocrine_pathology" title="Template:Endocrine pathology">Other</a></li>
<li><a href="/wiki/Template:Symptoms_concerning_nutrition,_metabolism_and_development" title="Template:Symptoms concerning nutrition, metabolism and development">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_endocrinology,_nutrition,_and_metabolism" title="Template:Eponymous medical signs for endocrinology, nutrition, and metabolism">eponymous</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Endocrine_system_procedures" title="Template:Endocrine system procedures">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Calcium_homeostasis" title="Template:Calcium homeostasis">calcium balance</a></li>
<li><a href="/wiki/Template:Corticosteroids" title="Template:Corticosteroids">corticosteroids</a></li>
<li><a href="/wiki/Template:Oral_hypoglycemics_and_insulin_analogs" title="Template:Oral hypoglycemics and insulin analogs">oral hypoglycemics</a></li>
<li><a href="/wiki/Template:Pituitary_and_hypothalamic_hormones_and_analogues" title="Template:Pituitary and hypothalamic hormones and analogues" class="mw-redirect">pituitary and hypothalamic</a></li>
<li><a href="/wiki/Template:Thyroid_therapy" title="Template:Thyroid therapy">thyroid</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Defects_of_cholesterol_and_steroid_metabolism" title="Template:Defects of cholesterol and steroid metabolism"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Defects_of_cholesterol_and_steroid_metabolism" title="Template talk:Defects of cholesterol and steroid metabolism"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Defects_of_cholesterol_and_steroid_metabolism&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">Inborn error</a> of <a href="/wiki/Inborn_error_of_steroid_metabolism" title="Inborn error of steroid metabolism" class="mw-redirect">steroid metabolism</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Mevalonate_pathway" title="Mevalonate pathway">Mevalonate pathway</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/3-hydroxy-3-methylglutaryl-CoA_lyase_deficiency" title="3-hydroxy-3-methylglutaryl-CoA lyase deficiency">HMG-CoA lyase deficiency</a></li>
</ul>
<ul>
<li><a href="/wiki/Hyper-IgD_syndrome" title="Hyper-IgD syndrome">Hyper-IgD syndrome</a></li>
<li><a href="/wiki/Mevalonate_kinase_deficiency" title="Mevalonate kinase deficiency">Mevalonate kinase deficiency</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">To <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/7-Dehydrocholesterol" title="7-Dehydrocholesterol">7-Dehydrocholesterol</a> path:</i> <a href="/wiki/Hydrops-ectopic_calcification-moth-eaten_skeletal_dysplasia" title="Hydrops-ectopic calcification-moth-eaten skeletal dysplasia">Hydrops-ectopic calcification-moth-eaten skeletal dysplasia</a></li>
<li><a href="/wiki/CHILD_syndrome" title="CHILD syndrome">CHILD syndrome</a></li>
<li><a href="/wiki/Conradi%E2%80%93H%C3%BCnermann_syndrome" title="Conradi–Hünermann syndrome">Conradi-Hünermann syndrome</a></li>
<li><a href="/wiki/Lathosterolosis" title="Lathosterolosis">Lathosterolosis</a></li>
<li><a href="/wiki/Smith-Lemli-Opitz_syndrome" title="Smith-Lemli-Opitz syndrome" class="mw-redirect">Smith-Lemli-Opitz syndrome</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Desmosterol" title="Desmosterol">desmosterol</a> path:</i> <a href="/wiki/Desmosterolosis" title="Desmosterolosis">Desmosterolosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Steroid" title="Steroid">Steroids</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Corticosteroid" title="Corticosteroid">Corticosteroid</a><br />
(including <a href="/wiki/Congenital_adrenal_hyperplasia" title="Congenital adrenal hyperplasia">CAH</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Aldosterone" title="Aldosterone">aldosterone</a>:</i> <a href="/wiki/Glucocorticoid_remediable_aldosteronism" title="Glucocorticoid remediable aldosteronism">Glucocorticoid remediable aldosteronism</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Cortisol" title="Cortisol">cortisol</a>/<a href="/wiki/Cortisone" title="Cortisone">cortisone</a>:</i> <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency">CAH 17α hydroxylase</a></li>
<li><a href="/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency">CAH 11β hydroxylase</a></li>
</ul>
<ul>
<li><i>both:</i> <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_3_beta-hydroxysteroid_dehydrogenase_deficiency" title="Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency">CAH 3β dehydrogenase</a></li>
<li><strong class="selflink">CAH 21α hydroxylase</strong></li>
<li><a href="/wiki/Apparent_mineralocorticoid_excess_syndrome" title="Apparent mineralocorticoid excess syndrome">Apparent mineralocorticoid excess syndrome/11β dehydrogenase</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Sex_steroid" title="Sex steroid">Sex steroid</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">To <a href="/wiki/Androgen" title="Androgen">androgens</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/17-beta-hydroxysteroid_dehydrogenase_deficiency" title="17-beta-hydroxysteroid dehydrogenase deficiency">17-beta-hydroxysteroid dehydrogenase deficiency</a></li>
<li><a href="/wiki/5-alpha-reductase_deficiency" title="5-alpha-reductase deficiency">5-alpha-reductase deficiency</a>
<ul>
<li><a href="/wiki/Pseudovaginal_perineoscrotal_hypospadias" title="Pseudovaginal perineoscrotal hypospadias">Pseudovaginal perineoscrotal hypospadias</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">To <a href="/wiki/Estrogen" title="Estrogen">estrogens</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Aromatase_deficiency" title="Aromatase deficiency">Aromatase deficiency</a></li>
<li><a href="/wiki/Aromatase_excess_syndrome" title="Aromatase excess syndrome">Aromatase excess syndrome</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/X-linked_ichthyosis" title="X-linked ichthyosis">X-linked ichthyosis</a></li>
<li><a href="/wiki/Antley-Bixler_syndrome" title="Antley-Bixler syndrome" class="mw-redirect">Antley-Bixler syndrome</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Metabolic_navs" title="Template:Metabolic navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Metabolic_navs" title="Template talk:Metabolic navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Metabolic_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">inborn errors of metabolism</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Metabolism" title="Template:Metabolism">Metabolism</a></li>
<li>Enzymes and pathways: <a href="/wiki/Template:Citric_acid_cycle" title="Template:Citric acid cycle">citric acid cycle</a>
<ul>
<li><a href="/wiki/Template:Citric_acid_cycle_enzymes_and_ETC" title="Template:Citric acid cycle enzymes and ETC">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_enzymes" title="Template:Pentose phosphate pathway enzymes">pentose phosphate</a>
<ul>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_intermediates" title="Template:Pentose phosphate pathway intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycoproteins" title="Template:Glycoproteins">glycoproteins</a>
<ul>
<li><a href="/wiki/Template:Glycoprotein_metabolism_enzymes" title="Template:Glycoprotein metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycosaminoglycans" title="Template:Glycosaminoglycans">glycosaminoglycans</a>
<ul>
<li><a href="/wiki/Template:Proteoglycan_metabolism_enzymes" title="Template:Proteoglycan metabolism enzymes">proteoglycan enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Phospholipids" title="Template:Phospholipids">phospholipid</a>
<ul>
<li><a href="/wiki/Template:Phospholipid_metabolism" title="Template:Phospholipid metabolism">metabolism</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Cholesterol_and_steroid_metabolism_enzymes" title="Template:Cholesterol and steroid metabolism enzymes">cholesterol and steroid</a>
<ul>
<li><a href="/wiki/Template:Cholesterol_and_steroid_intermediates" title="Template:Cholesterol and steroid intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Sphingolipids" title="Template:Sphingolipids">sphingolipids</a>
<ul>
<li><a href="/wiki/Template:Glycolipid/sphingolipid_metabolism_enzymes" title="Template:Glycolipid/sphingolipid metabolism enzymes" class="mw-redirect">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Eicosanoids" title="Template:Eicosanoids">eicosanoids</a>
<ul>
<li><a href="/wiki/Template:Eicosanoid_metabolism_enzymes" title="Template:Eicosanoid metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Amino_acid_metabolism_enzymes" title="Template:Amino acid metabolism enzymes">amino acid</a>
<ul>
<li><a href="/wiki/Template:Amino_acid_metabolism_intermediates" title="Template:Amino acid metabolism intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Urea_cycle" title="Template:Urea cycle">urea cycle</a>
<ul>
<li><a href="/wiki/Template:Urea_cycle_enzymes" title="Template:Urea cycle enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Nucleotide_metabolism_enzymes" title="Template:Nucleotide metabolism enzymes">nucleotide</a>
<ul>
<li><a href="/wiki/Template:Nucleotide_metabolism_intermediates" title="Template:Nucleotide metabolism intermediates">intermediates</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disorders</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Disorders_of_TCA_and_ETC" title="Template:Disorders of TCA and ETC">Citric acid cycle and electron transport chain</a></li>
<li><a href="/wiki/Template:Glycoprotein_disorders" title="Template:Glycoprotein disorders">Glycoprotein</a></li>
<li><a href="/wiki/Template:Proteoglycan_disorders" title="Template:Proteoglycan disorders">Proteoglycan</a></li>
<li><a href="/wiki/Template:Fatty-acid_metabolism_disorders" title="Template:Fatty-acid metabolism disorders">Fatty-acid</a></li>
<li><a href="/wiki/Template:Phospholipid_metabolism_disorders" title="Template:Phospholipid metabolism disorders">Phospholipid</a></li>
<li><a href="/wiki/Template:Defects_of_cholesterol_and_steroid_metabolism" title="Template:Defects of cholesterol and steroid metabolism">Cholesterol and steroid</a></li>
<li><a href="/wiki/Template:Eicosanoid_metabolism_disorders" title="Template:Eicosanoid metabolism disorders">Eicosanoid</a></li>
<li><a href="/wiki/Template:Amino_acid_metabolic_pathology" title="Template:Amino acid metabolic pathology">Amino acid</a></li>
<li><a href="/wiki/Template:Inborn_errors_of_purine-pyrimidine_metabolism" title="Template:Inborn errors of purine-pyrimidine metabolism">Purine-pyrimidine</a></li>
<li><a href="/wiki/Template:Heme_metabolism_disorders" title="Template:Heme metabolism disorders">Heme metabolism</a></li>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_endocrinology,_nutrition,_and_metabolism" title="Template:Eponymous medical signs for endocrinology, nutrition, and metabolism">Symptoms and signs</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Other_alimentary_tract_and_metabolism_products" title="Template:Other alimentary tract and metabolism products">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Endocrine_navs" title="Template:Endocrine navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Endocrine_navs" title="Template talk:Endocrine navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Endocrine_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Endocrine_system" title="Endocrine system">hormones</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Endocrine_system_anatomy" title="Template:Endocrine system anatomy">Glands</a></li>
<li><a href="/wiki/Template:Hormones" title="Template:Hormones">Hormones</a>
<ul>
<li>thyroid
<ul>
<li><i><a href="/wiki/Template:Thyroid_hormone_intermediates" title="Template:Thyroid hormone intermediates">intermediates</a></i></li>
<li><i><a href="/wiki/Template:Thyroid_hormone_metabolism_enzymes_and_transporters" title="Template:Thyroid hormone metabolism enzymes and transporters">metabolism</a></i></li>
</ul>
</li>
<li><a href="/wiki/Template:Mineralocorticoids" title="Template:Mineralocorticoids">mineralocorticoids</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Endocrinology_physiology" title="Template:Endocrinology physiology">Physiology</a></li>
<li><a href="/wiki/Template:Development_of_endocrine_system" title="Template:Development of endocrine system">Development</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Diabetes" title="Template:Diabetes">Diabetes</a></li>
<li><a href="/wiki/Template:Congenital_endocrine_disorders" title="Template:Congenital endocrine disorders">Congenital</a></li>
<li><a href="/wiki/Template:Endocrine_gland_neoplasia" title="Template:Endocrine gland neoplasia">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Endocrine_pathology" title="Template:Endocrine pathology">Other</a></li>
<li><a href="/wiki/Template:Symptoms_concerning_nutrition,_metabolism_and_development" title="Template:Symptoms concerning nutrition, metabolism and development">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_endocrinology,_nutrition,_and_metabolism" title="Template:Eponymous medical signs for endocrinology, nutrition, and metabolism">eponymous</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Endocrine_system_procedures" title="Template:Endocrine system procedures">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Calcium_homeostasis" title="Template:Calcium homeostasis">calcium balance</a></li>
<li><a href="/wiki/Template:Corticosteroids" title="Template:Corticosteroids">corticosteroids</a></li>
<li><a href="/wiki/Template:Oral_hypoglycemics_and_insulin_analogs" title="Template:Oral hypoglycemics and insulin analogs">oral hypoglycemics</a></li>
<li><a href="/wiki/Template:Pituitary_and_hypothalamic_hormones_and_analogues" title="Template:Pituitary and hypothalamic hormones and analogues" class="mw-redirect">pituitary and hypothalamic</a></li>
<li><a href="/wiki/Template:Thyroid_therapy" title="Template:Thyroid therapy">thyroid</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1178
CPU time usage: 0.442 seconds
Real time usage: 0.542 seconds
Preprocessor visited node count: 1932/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 187946/2097152 bytes
Template argument size: 541/2097152 bytes
Highest expansion depth: 8/40
Expensive parser function count: 3/500
Lua time usage: 0.155/10.000 seconds
Lua memory usage: 3.48 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  349.021      1 - -total
 46.02%  160.633     13 - Template:Navbox
 23.92%   83.496      1 - Template:Infobox_disease
 21.63%   75.492      1 - Template:Reflist
 20.92%   73.029      1 - Template:Infobox
 17.36%   60.575      1 - Template:Endocrine_pathology
 16.27%   56.770      1 - Template:Unreferenced-section
 15.58%   54.391      8 - Template:Cite_journal
 14.70%   51.318      2 - Template:Ambox
 13.99%   48.813      1 - Template:Unreferenced
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:802065-0!*!0!!en!4!* and timestamp 20150704220518 and revision id 668293620
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;oldid=668293620">https://en.wikipedia.org/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;oldid=668293620</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Adrenal_gland_disorders" title="Category:Adrenal gland disorders">Adrenal gland disorders</a></li><li><a href="/wiki/Category:Autosomal_recessive_disorders" title="Category:Autosomal recessive disorders">Autosomal recessive disorders</a></li><li><a href="/wiki/Category:Cholesterol_and_steroid_metabolism_disorders" title="Category:Cholesterol and steroid metabolism disorders">Cholesterol and steroid metabolism disorders</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_needing_additional_references_from_September_2012" title="Category:Articles needing additional references from September 2012">Articles needing additional references from September 2012</a></li><li><a href="/wiki/Category:All_articles_needing_additional_references" title="Category:All articles needing additional references">All articles needing additional references</a></li><li><a href="/wiki/Category:NPOV_disputes_from_September_2012" title="Category:NPOV disputes from September 2012">NPOV disputes from September 2012</a></li><li><a href="/wiki/Category:All_NPOV_disputes" title="Category:All NPOV disputes">All NPOV disputes</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Congenital+adrenal+hyperplasia+due+to+21-hydroxylase+deficiency&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Congenital+adrenal+hyperplasia+due+to+21-hydroxylase+deficiency" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;oldid=668293620" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q4127185" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;id=668293620" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Congenital+adrenal+hyperplasia+due+to+21-hydroxylase+deficiency">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Congenital+adrenal+hyperplasia+due+to+21-hydroxylase+deficiency&amp;oldid=668293620&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%92%D1%80%D0%BE%D0%B6%D0%B4%D1%91%D0%BD%D0%BD%D0%B0%D1%8F_%D0%B3%D0%B8%D0%BF%D0%B5%D1%80%D0%BF%D0%BB%D0%B0%D0%B7%D0%B8%D1%8F_%D0%BA%D0%BE%D1%80%D1%8B_%D0%BD%D0%B0%D0%B4%D0%BF%D0%BE%D1%87%D0%B5%D1%87%D0%BD%D0%B8%D0%BA%D0%BE%D0%B2_%D0%B2%D1%81%D0%BB%D0%B5%D0%B4%D1%81%D1%82%D0%B2%D0%B8%D0%B5_%D0%BD%D0%B5%D0%B4%D0%BE%D1%81%D1%82%D0%B0%D1%82%D0%BE%D1%87%D0%BD%D0%BE%D1%81%D1%82%D0%B8_21-%D0%B3%D0%B8%D0%B4%D1%80%D0%BE%D0%BA%D1%81%D0%B8%D0%BB%D0%B0%D0%B7%D1%8B" title="Врождённая гиперплазия коры надпочечников вследствие недостаточности 21-гидроксилазы – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q4127185#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 23 June 2015, at 14:17.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":98,"wgHostname":"mw1030"});
}</script>
	</body>
</html>
